A	O
novel	O
NF-kappa	B-protein
B	I-protein
complex	I-protein
containing	O
p65	B-protein
homodimers	I-protein
:	O
implications	O
for	O
transcriptional	O
control	O
at	O
the	O
level	O
of	O
subunit	O
dimerization	O
.	O

The	O
predominant	O
inducible	O
form	O
of	O
the	O
NF-kappa	B-protein
B	I-protein
transcription	I-protein
factor	I-protein
is	O
a	O
heteromeric	B-protein
complex	I-protein
containing	O
two	O
Rel-related	B-protein
DNA-binding	I-protein
subunits	I-protein
,	O
termed	B-protein
p65	I-protein
and	O
p50	B-protein
.	O

Prior	O
transfection	O
studies	O
have	O
shown	O
that	O
when	O
these	O
p65	B-protein
and	I-protein
p50	I-protein
subunits	I-protein
are	O
expressed	O
independently	O
as	O
stable	B-protein
homodimers	I-protein
,	O
p65	B-protein
stimulates	O
kappa	O
B-directed	O
transcription	O
,	O
whereas	O
p50	B-protein
functions	O
as	O
a	O
kappa	O
B-specific	O
repressor	O
.	O

While	O
authentic	O
p50	B-protein
homodimers	I-protein
(	O
previously	O
termed	O
KBF1	B-protein
)	O
have	O
been	O
detected	O
in	O
nuclear	O
extracts	O
from	O
nontransfected	O
cells	O
,	O
experimental	O
evidence	O
supporting	O
the	O
existence	O
of	O
p65	B-protein
homodimers	I-protein
in	O
vivo	O
was	O
lacking	O
.	O

We	O
now	O
provide	O
direct	O
biochemical	O
evidence	O
for	O
the	O
presence	O
of	O
an	O
endogenous	O
pool	O
of	O
inducible	O
p65	B-protein
homodimers	I-protein
in	O
intact	O
human	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

As	O
with	O
the	O
prototypical	O
NF-kappa	B-protein
B	I-protein
p50-p65	I-protein
heterodimer	I-protein
,	O
this	O
novel	O
p65	B-protein
homodimeric	I-protein
form	I-protein
of	O
NF-kappa	B-protein
B	I-protein
is	O
functionally	O
sequestered	O
in	O
the	O
cytoplasm	O
but	O
rapidly	O
appears	O
in	O
the	O
nuclear	O
compartment	O
following	O
cellular	O
stimulation	O
.	O

Site-directed	O
mutagenesis	O
studies	O
indicate	O
that	O
the	O
homodimerization	O
function	O
of	O
p65	B-protein
is	O
dependent	O
upon	O
the	O
presence	O
of	O
cysteine	O
216	O
and	O
a	O
conserved	O
recognition	O
motif	O
for	O
protein	B-protein
kinase	I-protein
A	I-protein
(	O
RRPS	B-protein
;	O
amino	O
acids	O
273	O
to	O
276	O
)	O
,	O
both	O
of	O
which	O
reside	O
within	O
a	O
91-amino-acid	O
segment	O
of	O
the	O
Rel	B-protein
homology	I-protein
domain	I-protein
that	O
mediates	O
self-association	O
.	O

In	O
contrast	O
,	O
mutations	O
at	O
these	O
two	O
sites	O
do	O
not	O
affect	O
heterodimerization	O
of	O
p65	B-protein
with	O
p50	B-protein
or	O
its	O
functional	O
interaction	O
with	O
I	O
kappa	O
B	O
alpha	O
.	O

These	O
later	O
findings	O
indicate	O
that	O
neither	O
homo-	O
nor	O
heterodimer	O
formation	O
is	O
an	O
absolute	O
prerequisite	O
for	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
recognition	O
of	O
p65	B-protein
.	O

Taken	O
together	O
with	O
prior	O
in	O
vivo	O
transcription	O
studies	O
,	O
these	O
results	O
suggest	O
that	O
the	O
biological	O
activities	O
of	O
p65	B-protein
and	I-protein
p50	I-protein
homodimers	I-protein
are	O
independently	O
regulated	O
,	O
thereby	O
providing	O
an	O
integrated	O
and	O
flexible	O
control	O
mechanism	O
for	O
the	O
rapid	O
activation	O
and	O
repression	O
of	O
NF-kappa	B-protein
B	I-protein
/	O
Rel	B-protein
-directed	O
gene	O
expression	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLogy	NULL
,	NULL
Dec.	NULL
1993	NULL
,	NULL
p.	NULL
7826-7835	NULL
0270-7306/93/127826-10	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

12	NULL
A	NULL
Novel	NULL
NF-kB	NULL
Complex	NULL
Containing	NULL
p65	NULL
Homodimers	NULL
:	NULL
Implications	NULL
for	NULL
Transcriptional	NULL
Control	NULL
at	NULL
the	NULL
Level	NULL
of	NULL
Subunit	NULL
Dimerization	NULL
PARHAM	NULL
A.	NULL
GANCHI	NULL
,	NULL
'	NULL
SHAO-CONG	NULL
SUN	NULL
,	NULL
``	NULL
WARNER	NULL
C.	NULL
GREENE	NULL
,	NULL
anp	NULL
DEAN	NULL
W.	NULL
BALLARD*®*	NULL
Gladstone	NULL
Institute	NULL
of	NULL
Virology	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
San	NULL
Francisco	NULL
General	NULL
Hospital	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94141-9100	NULL
,	NULL
and	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Vanderbilt	NULL
University	NULL
,	NULL
802	NULL
Light	NULL
Hall	NULL
,	NULL
Nashville	NULL
,	NULL
Tennessee	NULL
37232-02952	NULL
Received	NULL
19	NULL
May	NULL
1993/Returned	NULL
for	NULL
modification	NULL
10	NULL
July	NULL
1993/Accepted	NULL
15	NULL
September	NULL
1993	NULL
The	NULL
predominant	NULL
inducible	NULL
form	NULL
of	NULL
the	NULL
NF-	NULL
<	NULL
B	NULL
transcription	NULL
factor	NULL
is	NULL
a	NULL
heteromeric	NULL
complex	NULL
containing	NULL
two	NULL
Rel-related	NULL
DNA-binding	NULL
subunits	NULL
,	NULL
termed	NULL
p65	NULL
and	NULL
p50	NULL
.	NULL

Prior	NULL
transfection	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
when	NULL
these	NULL
p65	NULL
and	NULL
p50	NULL
subunits	NULL
are	NULL
expressed	NULL
independently	NULL
as	NULL
stable	NULL
homodimers	NULL
,	NULL
p6S	NULL
stimulates	NULL
B-directed	NULL
transcription	NULL
,	NULL
whereas	NULL
pS0	NULL
functions	NULL
as	NULL
a	NULL
«	NULL
B-specific	NULL
repressor	NULL
.	NULL

While	NULL
authentic	NULL
p50	NULL
homodimers	NULL
(	NULL
previously	NULL
termed	NULL
KBF1	NULL
)	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
nontransfected	NULL
cells	NULL
,	NULL
experimental	NULL
evidence	NULL
supporting	NULL
the	NULL
existence	NULL
of	NULL
p65	NULL
homodimers	NULL
in	NULL
vivo	NULL
was	NULL
lacking	NULL
.	NULL

We	NULL
now	NULL
provide	NULL
direct	NULL
biochemical	NULL
evidence	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
endogenous	NULL
pool	NULL
of	NULL
inducible	NULL
p65	NULL
homodimers	NULL
in	NULL
intact	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
with	NULL
the	NULL
prototypical	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
heterodimer	NULL
,	NULL
this	NULL
novel	NULL
p65	NULL
homodimeric	NULL
form	NULL
of	NULL
NF-B	NULL
is	NULL
functionally	NULL
sequestered	NULL
in	NULL
the	NULL
cytoplasm	NULL
but	NULL
rapidly	NULL
appears	NULL
in	NULL
the	NULL
nuclear	NULL
compartment	NULL
following	NULL
cellular	NULL
stimulation	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
homodimerization	NULL
function	NULL
of	NULL
p65	NULL
is	NULL
dependent	NULL
upon	NULL
the	NULL
presence	NULL
of	NULL
cysteine	NULL
216	NULL
and	NULL
a	NULL
conserved	NULL
recognition	NULL
motif	NULL
for	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
RRPS	NULL
;	NULL
amino	NULL
acids	NULL
273	NULL
to	NULL
276	NULL
)	NULL
,	NULL
both	NULL
of	NULL
which	NULL
reside	NULL
within	NULL
a	NULL
91-amino-acid	NULL
segment	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
that	NULL
mediates	NULL
self-association	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutations	NULL
at	NULL
these	NULL
two	NULL
sites	NULL
do	NULL
not	NULL
affect	NULL
heterodimerization	NULL
of	NULL
p6S	NULL
with	NULL
p50	NULL
or	NULL
its	NULL
functional	NULL
interaction	NULL
with	NULL
IxBa	NULL
.	NULL

These	NULL
later	NULL
findings	NULL
indicate	NULL
that	NULL
neither	NULL
homo-	NULL
nor	NULL
heterodimer	NULL
formation	NULL
is	NULL
an	NULL
absolute	NULL
prerequisite	NULL
for	NULL
IBa	NULL
recognition	NULL
of	NULL
p65	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
prior	NULL
in	NULL
vivo	NULL
transcription	NULL
studies	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
biological	NULL
activities	NULL
of	NULL
p65	NULL
and	NULL
p50	NULL
homodimers	NULL
are	NULL
independently	NULL
regulated	NULL
,	NULL
thereby	NULL
providing	NULL
an	NULL
integrated	NULL
and	NULL
flexible	NULL
control	NULL
mechanism	NULL
for	NULL
the	NULL
rapid	NULL
activation	NULL
and	NULL
repression	NULL
of	NULL
NF-B/Rel-	NULL
directed	NULL
gene	NULL
expression	NULL
.	NULL

Nuclear	NULL
induction	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
complex	NULL
is	NULL
an	NULL
important	NULL
convergent	NULL
step	NULL
in	NULL
several	NULL
distinct	NULL
receptor-mediated	NULL
signaling	NULL
pathways	NULL
that	NULL
potentiate	NULL
the	NULL
growth	NULL
response	NULL
of	NULL
activated	NULL
T	NULL
lymphocytes	NULL
(	NULL
19	NULL
,	NULL
26	NULL
,	NULL
39	NULL
,	NULL
62	NULL
)	NULL
.	NULL

This	NULL
specific	NULL
inductive	NULL
event	NULL
is	NULL
initiated	NULL
upon	NULL
cellular	NULL
stimulation	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
soluble	NULL
mediators	NULL
,	NULL
including	NULL
T-cell	NULL
receptor	NULL
ligands	NULL
(	NULL
22	NULL
,	NULL
29	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
,	NULL
interleukin-1	NULL
(	NULL
52	NULL
,	NULL
63	NULL
)	NULL
,	NULL
interleukin-2	NULL
(	NULL
3	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
40	NULL
,	NULL
52	NULL
)	NULL
,	NULL
and	NULL
phorbol	NULL
esters	NULL
(	NULL
5	NULL
,	NULL
12	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
revealed	NULL
that	NULL
the	NULL
major	NULL
inducible	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
corresponds	NULL
to	NULL
a	NULL
heterodimeric	NULL
complex	NULL
composed	NULL
of	NULL
65-kDa	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
50-kDa	NULL
(	NULL
p50	NULL
)	NULL
subunits	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
DNA-binding	NULL
proteins	NULL
has	NULL
extensive	NULL
amino	NULL
acid	NULL
sequence	NULL
homology	NULL
with	NULL
the	NULL
N-terminal	NULL
halves	NULL
of	NULL
the	NULL
v-Rel	NULL
oncoprotein	NULL
,	NULL
its	NULL
cellular	NULL
homolog	NULL
c-Rel	NULL
,	NULL
and	NULL
the	NULL
Drosophila	NULL
morphogen	NULL
Dorsal	NULL
(	NULL
13	NULL
,	NULL
24	NULL
,	NULL
36	NULL
,	NULL
42	NULL
,	NULL
50	NULL
,	NULL
55	NULL
;	NULL
reviewed	NULL
in	NULL
reference	NULL
25	NULL
)	NULL
.	NULL

The	NULL
induced	NULL
nuclear	NULL
expression	NULL
of	NULL
this	NULL
p50-p65	NULL
complex	NULL
is	NULL
believed	NULL
to	NULL
involve	NULL
the	NULL
phosphorylation	NULL
,	NULL
dissociation	NULL
,	NULL
and	NULL
subsequent	NULL
degradation	NULL
of	NULL
an	NULL
associated	NULL
cytoplasmic	NULL
inhibitor	NULL
now	NULL
termed	NULL
IxBa	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
17	NULL
,	NULL
23	NULL
,	NULL
27	NULL
,	NULL
65	NULL
)	NULL
.	NULL

The	NULL
recent	NULL
finding	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
also	NULL
specifically	NULL
activates	NULL
IxBa	NULL
gene	NULL
expression	NULL
indicates	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
autoregulatory	NULL
feedback	NULL
mechanism	NULL
that	NULL
ensures	NULL
the	NULL
rapid	NULL
but	NULL
transient	NULL
biological	NULL
action	NULL
of	NULL
nuclear	NULL
NF-KB	NULL
(	NULL
17	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Previous	NULL
investigations	NULL
have	NULL
firmly	NULL
established	NULL
that	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
primarily	NULL
responsible	NULL
for	NULL
both	NULL
the	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

7826	NULL
transactivation	NULL
function	NULL
(	NULL
8	NULL
,	NULL
57	NULL
,	NULL
60	NULL
)	NULL
and	NULL
IxBa-mediated	NULL
repression	NULL
of	NULL
the	NULL
heterodimeric	NULL
p65-p50	NULL
complex	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
21	NULL
,	NULL
27	NULL
,	NULL
50	NULL
,	NULL
55	NULL
,	NULL
65	NULL
,	NULL
68	NULL
)	NULL
.	NULL

This	NULL
DNA-binding	NULL
subunit	NULL
contains	NULL
an	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
approximately	NULL
300	NULL
amino	NULL
acids	NULL
and	NULL
a	NULL
C-terminal	NULL
transactivation	NULL
domain	NULL
that	NULL
is	NULL
lacking	NULL
in	NULL
the	NULL
p50	NULL
subunit	NULL
(	NULL
8	NULL
,	NULL
13	NULL
,	NULL
24	NULL
,	NULL
36	NULL
,	NULL
42	NULL
,	NULL
50	NULL
,	NULL
55	NULL
,	NULL
57	NULL
,	NULL
60	NULL
)	NULL
.	NULL

Comparative	NULL
functional	NULL
studies	NULL
with	NULL
transfected	NULL
genes	NULL
have	NULL
further	NULL
suggested	NULL
that	NULL
p65	NULL
homodimers	NULL
can	NULL
induce	NULL
«	NULL
B-dependent	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
p50	NULL
(	NULL
8	NULL
,	NULL
57	NULL
,	NULL
60	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
p50	NULL
homodimers	NULL
(	NULL
originally	NULL
termed	NULL
KBF1	NULL
)	NULL
(	NULL
32	NULL
,	NULL
36	NULL
,	NULL
71	NULL
)	NULL
appear	NULL
to	NULL
act	NULL
as	NULL
xB-specific	NULL
repressors	NULL
in	NULL
vivo	NULL
(	NULL
20	NULL
,	NULL
34	NULL
,	NULL
60	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
strong	NULL
activation	NULL
domain	NULL
within	NULL
this	NULL
polypeptide	NULL
.	NULL

Furthermore	NULL
,	NULL
while	NULL
can	NULL
trap	NULL
both	NULL
p65	NULL
and	NULL
p50	NULL
homodimers	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
11	NULL
,	NULL
21	NULL
)	NULL
,	NULL
this	NULL
inhibitor	NULL
selectively	NULL
blocks	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
p65	NULL
only	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
21	NULL
,	NULL
50	NULL
,	NULL
55	NULL
,	NULL
68	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
indicate	NULL
that	NULL
dissociation	NULL
of	NULL
the	NULL
IxBa	NULL
subunit	NULL
unmasks	NULL
a	NULL
functional	NULL
nuclear	NULL
localization	NULL
signal	NULL
present	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
11	NULL
,	NULL
21	NULL
)	NULL
,	NULL
thereby	NULL
allowing	NULL
its	NULL
rapid	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
this	NULL
inducible	NULL
complex	NULL
acts	NULL
in	NULL
concert	NULL
with	NULL
other	NULL
constitutive	NULL
transcription	NULL
factors	NULL
to	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
select	NULL
T-cell	NULL
activation	NULL
genes	NULL
(	NULL
7	NULL
,	NULL
12	NULL
,	NULL
19	NULL
,	NULL
26	NULL
,	NULL
31	NULL
,	NULL
34	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Although	NULL
conclusive	NULL
biochemical	NULL
evidence	NULL
for	NULL
inducible	NULL
p50-p65	NULL
heterodimers	NULL
(	NULL
6	NULL
)	NULL
and	NULL
constitutive	NULL
pS50-p50	NULL
homodimers	NULL
(	NULL
KBF1	NULL
)	NULL
(	NULL
20	NULL
,	NULL
32	NULL
,	NULL
34	NULL
,	NULL
36	NULL
,	NULL
71	NULL
)	NULL
has	NULL
been	NULL
assembled	NULL
,	NULL
it	NULL
remained	NULL
unclear	NULL
whether	NULL
endogenous	NULL
p6S5-p65	NULL
homodimers	NULL
are	NULL
in	NULL
fact	NULL
present	NULL
in	NULL
nontransfected	NULL
cells	NULL
.	NULL

We	NULL
now	NULL
show	NULL
that	NULL
p65	NULL
homodimers	NULL
exist	NULL
as	NULL
an	NULL
inducible	NULL
detergent-sensitive	NULL
pool	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
nontransfected	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
and	NULL
appear	NULL
within	NULL
the	NULL
nucleus	NULL
following	NULL
cellular	NULL
stimulation	NULL
with	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
domain	NULL
of	NULL
p65	NULL
that	NULL
mediates	NULL
homodimerization	NULL
is	NULL
located	NULL
within	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
that	NULL
is	NULL
required	NULL
for	NULL
IxBa	NULL
binding	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
studies	NULL
have	NULL
identified	NULL
two	NULL
important	NULL
amino	NULL
acid	NULL
residues	NULL
within	NULL
this	NULL
Rel	NULL
homology	NULL
subregion	NULL
that	NULL
are	NULL
required	NULL
for	NULL
p65	NULL
homodimerization	NULL
but	NULL
not	NULL
for	NULL
heterodimerization	NULL
with	NULL
p50	NULL
.	NULL

One	NULL
of	NULL
these	NULL
determinants	NULL
corresponds	NULL
to	NULL
the	NULL
only	NULL
conserved	NULL
cysteine	NULL
residue	NULL
present	NULL
within	NULL
this	NULL
interaction	NULL
domain	NULL
(	NULL
Cys-216	NULL
)	NULL
.	NULL

The	NULL
other	NULL
represents	NULL
a	NULL
conserved	NULL
serine	NULL
residue	NULL
present	NULL
within	NULL
a	NULL
consensus	NULL
recognition	NULL
sequence	NULL
for	NULL
cyclic	NULL
AMP	NULL
(	NULL
cAMP	NULL
)	NULL
-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
RRPS	NULL
;	NULL
amino	NULL
acids	NULL
273	NULL
to	NULL
276	NULL
)	NULL
(	NULL
25	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
mutations	NULL
affecting	NULL
these	NULL
specific	NULL
amino	NULL
acids	NULL
failed	NULL
to	NULL
prevent	NULL
functional	NULL
association	NULL
of	NULL
the	NULL
resultant	NULL
p65	NULL
monomers	NULL
with	NULL
the	NULL
inhibitor	NULL
IxBa	NULL
,	NULL
thus	NULL
indicating	NULL
that	NULL
dimerization	NULL
is	NULL
not	NULL
an	NULL
absolute	NULL
prerequisite	NULL
for	NULL
the	NULL
assembly	NULL
of	NULL
p65-IxBa	NULL
complexes	NULL
in	NULL
the	NULL
cytoplasm	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Expression	NULL
vectors	NULL
and	NULL
reporter	NULL
plasmids	NULL
.	NULL

The	NULL
pCMV4-based	NULL
expression	NULL
vectors	NULL
(	NULL
2	NULL
)	NULL
encoding	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
(	NULL
8	NULL
,	NULL
55	NULL
)	NULL
,	NULL
p50	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
461	NULL
)	NULL
(	NULL
36	NULL
)	NULL
,	NULL
IxBa	NULL
(	NULL
27	NULL
)	NULL
,	NULL
and	NULL
all	NULL
truncation	NULL
mutants	NULL
of	NULL
p65	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Site-directed	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
wild-type	NULL
p65	NULL
by	NULL
using	NULL
phosphorothioate	NULL
chemistry	NULL
(	NULL
47	NULL
)	NULL
and	NULL
specific	NULL
oligonucleotide	NULL
primers	NULL
that	NULL
introduced	NULL
diagnostic	NULL
restriction	NULL
sites	NULL
.	NULL

The	NULL
«	NULL
B	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
«	NULL
B	NULL
enhancer	NULL
motif	NULL
and	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
gene	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
64	NULL
)	NULL
.	NULL

Cell	NULL
transfections	NULL
,	NULL
extract	NULL
preparations	NULL
,	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
monkey	NULL
kidney	NULL
cell	NULL
line	NULL
COS	NULL
and	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
Iscove	NULL
's	NULL
and	NULL
RPMI	NULL
media	NULL
,	NULL
respectively	NULL
,	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
and	NULL
antibiotics	NULL
.	NULL

Effector	NULL
and	NULL
reporter	NULL
plasmids	NULL
were	NULL
introduced	NULL
into	NULL
both	NULL
cell	NULL
lines	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
(	NULL
30	NULL
)	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
metabolically	NULL
radiolabeled	NULL
with	NULL
both	NULL
[	NULL
**S	NULL
)	NULL
Jmethio-nine	NULL
and	NULL
[	NULL
°*SJcysteine	NULL
,	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
under	NULL
previously	NULL
described	NULL
detergent	NULL
lysis	NULL
conditions	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Jurkat	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
before	NULL
or	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
(	NULL
50	NULL
ng/ml	NULL
;	NULL
2.5	NULL
h	NULL
)	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
61	NULL
)	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
whole-cell	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cell	NULL
transfectants	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
15	NULL
,	NULL
49	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
studies	NULL
.	NULL

A	NULL
functional	NULL
palindromic	NULL
variant	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
«	NULL
B	NULL
enhancer	NULL
sequence	NULL
(	NULL
5'-CAACGGCAGGGGAATTCCCCTCTCCIT-3	NULL
'	NULL
)	NULL
(	NULL
«	NULL
B-pd	NULL
)	NULL
(	NULL
9	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
~10	NULL
fmol	NULL
,	NULL
200,000	NULL
cpm	NULL
)	NULL
in	NULL
DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
(	NULL
20	NULL
wl	NULL
)	NULL
that	NULL
contained	NULL
protein	NULL
extract	NULL
(	NULL
10	NULL
to	NULL
20	NULL
ug	NULL
)	NULL
and	NULL
0.2	NULL
ug	NULL
of	NULL
double-stranded	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
)	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
-5	NULL
%	NULL
glycerol-1	NULL
mM	NULL
EDTA-0.5	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml-1	NULL
%	NULL
Nonidet	NULL
P-40-5	NULL
mM	NULL
dithiothreitol	NULL
(	NULL
7	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Deoxycholate	NULL
(	NULL
0.5	NULL
%	NULL
)	NULL
(	NULL
5	NULL
)	NULL
or	NULL
specific	NULL
polyclonal	NULL
antisera	NULL
(	NULL
1	NULL
wl	NULL
)	NULL
were	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
were	NULL
resolved	NULL
on	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
(	NULL
12	NULL
)	NULL
.	NULL

For	NULL
UV	NULL
cross-linking	NULL
analyses	NULL
(	NULL
7	NULL
,	NULL
44	NULL
)	NULL
,	NULL
polyacrylamide	NULL
gels	NULL
containing	NULL
the	NULL
fractionated	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
irradiated	NULL
at	NULL
300	NULL
nm	NULL
for	NULL
20	NULL
min	NULL
.	NULL

Gel	NULL
slices	NULL
corresponding	NULL
to	NULL
specific	NULL
nucleoprotein	NULL
complexes	NULL
were	NULL
excised	NULL
,	NULL
boiled	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
4	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-5	NULL
%	NULL
B-mercapto-ethanol-8	NULL
M	NULL
urea	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
SDS-polyacrylamide	NULL
gel	NULL
HOMODIMERIZATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
7827	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
radiolabeled	NULL
adducts	NULL
were	NULL
passively	NULL
eluted	NULL
from	NULL
crushed	NULL
gel	NULL
slices	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-140	NULL
mM	NULL
NaCl-1	NULL
%	NULL
deoxycholate-1	NULL
%	NULL
Triton	NULL
X-100-0.1	NULL
%	NULL
SDS-0.1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml-2.5	NULL
%	NULL
glycerol-1	NULL
mM	NULL
dithiothreitol	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
to	NULL
20	NULL
h	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
as	NULL
described	NULL
below	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblot	NULL
analyses	NULL
.	NULL

Expression	NULL
of	NULL
transfected	NULL
wild-type	NULL
and	NULL
mutated	NULL
p65	NULL
cDNAs	NULL
was	NULL
monitored	NULL
by	NULL
using	NULL
specific	NULL
antipeptide	NULL
antibodies	NULL
raised	NULL
against	NULL
the	NULL
unique	NULL
N-	NULL
and	NULL
C-terminal	NULL
sequences	NULL
of	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
21	NULL
and	NULL
535	NULL
to	NULL
551	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
100	NULL
ul	NULL
of	NULL
**S-labeled	NULL
COS	NULL
cell	NULL
extract	NULL
was	NULL
sequentially	NULL
precleared	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
appropriate	NULL
p6S-specific	NULL
antiserum	NULL
,	NULL
washed	NULL
extensively	NULL
in	NULL
lysis	NULL
buffer	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
COS	NULL
cell	NULL
extracts	NULL
were	NULL
fractionated	NULL
on	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
filters	NULL
,	NULL
and	NULL
probed	NULL
with	NULL
an	NULL
antibody	NULL
recognizing	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
IxBa	NULL
(	NULL
amino	NULL
acids	NULL
289	NULL
to	NULL
317	NULL
)	NULL
.	NULL

Immunoreactive	NULL
species	NULL
were	NULL
detected	NULL
by	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
assay	NULL
(	NULL
21	NULL
)	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Amersham	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

RESULTS	NULL
Activation	NULL
of	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
induces	NULL
nuclear	NULL
expression	NULL
of	NULL
p65	NULL
homodimers	NULL
.	NULL

As	NULL
described	NULL
above	NULL
,	NULL
it	NULL
has	NULL
remained	NULL
unclear	NULL
whether	NULL
endogenous	NULL
p65	NULL
homodimeric	NULL
complexes	NULL
actually	NULL
exist	NULL
in	NULL
nontransfected	NULL
cells	NULL
as	NULL
a	NULL
physiologically	NULL
relevant	NULL
transcription	NULL
factor	NULL
species	NULL
.	NULL

To	NULL
directly	NULL
address	NULL
this	NULL
possibility	NULL
,	NULL
optimum	NULL
parameters	NULL
for	NULL
the	NULL
detection	NULL
of	NULL
p65	NULL
homodimer	NULL
DNA	NULL
binding	NULL
were	NULL
first	NULL
determined	NULL
by	NULL
using	NULL
whole-cell	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
pCMV4-p65	NULL
,	NULL
a	NULL
recombinant	NULL
cDNA	NULL
expression	NULL
vector	NULL
that	NULL
directs	NULL
the	NULL
high-level	NULL
synthesis	NULL
of	NULL
human	NULL
p65	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
studies	NULL
using	NULL
either	NULL
renatured	NULL
or	NULL
recombinant	NULL
p65	NULL
protein	NULL
(	NULL
9	NULL
,	NULL
38	NULL
)	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
both	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
nonspecific	NULL
competitor	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
added	NULL
and	NULL
the	NULL
precise	NULL
sequence	NULL
of	NULL
the	NULL
radiolabeled	NULL
«	NULL
B	NULL
enhancer	NULL
probe	NULL
significantly	NULL
influenced	NULL
the	NULL
detection	NULL
of	NULL
p65	NULL
homodimers	NULL
.	NULL

Cytoplasmic	NULL
extracts	NULL
from	NULL
human	NULL
Jurkat	NULL
cells	NULL
were	NULL
tested	NULL
by	NULL
using	NULL
these	NULL
p65	NULL
DNA	NULL
binding	NULL
conditions	NULL
in	NULL
combination	NULL
with	NULL
deoxycholate	NULL
,	NULL
a	NULL
detergent	NULL
known	NULL
to	NULL
dissociate	NULL
IxBa	NULL
from	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65-p50	NULL
heterodimer	NULL
in	NULL
vitro	NULL
(	NULL
5	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
a	NULL
discrete	NULL
nucleoprotein	NULL
complex	NULL
was	NULL
detected	NULL
at	NULL
low	NULL
concentrations	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
10	NULL
ng/ul	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
;	NULL
this	NULL
complex	NULL
comigrated	NULL
with	NULL
COS-derived	NULL
p65	NULL
homodimers	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
exhibited	NULL
a	NULL
mobility	NULL
that	NULL
was	NULL
significantly	NULL
slower	NULL
than	NULL
that	NULL
of	NULL
the	NULL
prototypical	NULL
p65-p50	NULL
heterodimeric	NULL
complex	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
small	NULL
amounts	NULL
of	NULL
a	NULL
complex	NULL
with	NULL
an	NULL
indistinguishable	NULL
electrophoretic	NULL
mobility	NULL
were	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
these	NULL
cells	NULL
following	NULL
stimulation	NULL
with	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
an	NULL
agent	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
rapid	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-KB	NULL
(	NULL
5	NULL
,	NULL
12	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Two	NULL
complementary	NULL
experimental	NULL
approaches	NULL
were	NULL
employed	NULL
to	NULL
assess	NULL
whether	NULL
this	NULL
slowly	NULL
migrating	NULL
nucleoprotein	NULL
complex	NULL
in	NULL
fact	NULL
corresponded	NULL
to	NULL
authentic	NULL
p65	NULL
homodimers	NULL
.	NULL

First	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
containing	NULL
these	NULL
various	NULL
complexes	NULL
were	NULL
reacted	NULL
with	NULL
either	NULL
anti-p65-	NULL
or	NULL
anti-p50-specific	NULL
antibodies	NULL
prior	NULL
to	NULL
electrophoresis	NULL
under	NULL
native	NULL
gel	NULL
retardation	NULL
conditions	NULL
.	NULL

In	NULL
accord	NULL
with	NULL
its	NULL
indistinguishable	NULL
mobility	NULL
relative	NULL
to	NULL
COS-derived	NULL
p65	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
,	NULL
the	NULL
slowly	NULL
migrating	NULL
complex	NULL
detected	NULL
in	NULL
either	NULL
cytoplasmic	NULL
or	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
were	NULL
``	NULL
supershifted	NULL
``	NULL
'	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-p65	NULL
antiserum	NULL
(	NULL
lanes	NULL
8	NULL
and	NULL
11	NULL
)	NULL
but	NULL
not	NULL
with	NULL
either	NULL
preimmune	NULL
7828	NULL
GANCHI	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

pesipso	NULL
>	NULL
@	NULL
R	NULL
...	NULL
“	NULL
a	NULL
‘	NULL
ap	NULL
~	NULL
a	NULL
-	NULL
was	NULL
C	NULL
QK	NULL
eL	NULL
.	NULL

eK	NULL
K	NULL
K	NULL
K	NULL
K	NULL
C_	NULL
K	NULL
K	NULL
\	NULL
C_	NULL
K	NULL
A	NULL
tR	NULL
¢	NULL
3,0	NULL
:	NULL
Q	NULL
%	NULL
;	NULL
‘	NULL
>	NULL
oo	NULL
``	NULL
a	NULL
``	NULL
C	NULL
49g	NULL
,	NULL
n	NULL
ap	NULL
``	NULL
``	NULL
3	NULL
4p	NULL
``	NULL
44	NULL
tp	NULL
~	NULL
*	NULL
>	NULL
cos	NULL
Jurkat	NULL
p50	NULL
COS	NULL
pés	NULL
COS	NULL
CYTO-DOC	NULL
NUC-PMA	NULL
c	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
D	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
5	NULL
aa	NULL
»	NULL
was	NULL
die	NULL
woe	NULL
age	NULL
it	NULL
``	NULL
La	NULL
Jy	NULL
.	NULL

#	NULL
.	NULL

°	NULL
a	NULL
``	NULL
K	NULL
3	NULL
%	NULL
p	NULL
46	NULL
%	NULL
%	NULL
%	NULL
%	NULL
NUC-PMA	NULL
pWDNA	NULL
’	NULL
.	NULL

“	NULL
@	NULL
to	NULL
is	NULL
p50DNA	NULL
>	NULL
L	NULL
p	NULL
°va~	NULL
eh	NULL
43	NULL
q	NULL
;	NULL
”	NULL
“	NULL
o	NULL
4	NULL
&	NULL
3	NULL
*	NULL
%	NULL
p65/p65	NULL
4G	NULL
:	NULL
p65/p65	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Endogenous	NULL
p65	NULL
homodimers	NULL
exist	NULL
as	NULL
an	NULL
inducible	NULL
detergent-sensitive	NULL
pool	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Cytoplasmic	NULL
(	NULL
CYTO	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
NUC	NULL
)	NULL
extracts	NULL
from	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
radiolabeled	NULL
kB	NULL
enhancer	NULL
probe	NULL
and	NULL
resolved	NULL
on	NULL
a	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
reaction	NULL
analyzed	NULL
in	NULL
lane	NULL
4	NULL
was	NULL
supplemented	NULL
with	NULL
0.5	NULL
%	NULL
deoxycholate	NULL
prior	NULL
to	NULL
electrophoresis	NULL
.	NULL

NUC-PMA	NULL
refers	NULL
to	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Jurkat	NULL
cells	NULL
stimulated	NULL
with	NULL
50	NULL
ng	NULL
of	NULL
PMA	NULL
per	NULL
ml	NULL
for	NULL
2.5	NULL
h	NULL
prior	NULL
to	NULL
analysis	NULL
.	NULL

The	NULL
arrows	NULL
identify	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
p65	NULL
homodimers	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
containing	NULL
extracts	NULL
described	NULL
for	NULL
panel	NULL
A	NULL
were	NULL
supplemented	NULL
with	NULL
preimmune	NULL
(	NULL
PI	NULL
)	NULL
,	NULL
anti-p65	NULL
(	NULL
«	NULL
p65	NULL
)	NULL
,	NULL
or	NULL
anti-p50	NULL
(	NULL
«	NULL
ap50	NULL
)	NULL
antiserum	NULL
prior	NULL
to	NULL
electrophoresis	NULL
.	NULL

Supershifted	NULL
species	NULL
are	NULL
identified	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
containing	NULL
nuclear	NULL
extracts	NULL
from	NULL
PMA-stimulated	NULL
(	NULL
45	NULL
min	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
supplemented	NULL
with	NULL
preimmune	NULL
(	NULL
PI	NULL
)	NULL
or	NULL
antipeptide	NULL
antisera	NULL
raised	NULL
against	NULL
the	NULL
indicated	NULL
Rel-related	NULL
proteins	NULL
prior	NULL
to	NULL
gel	NULL
shift	NULL
analysis	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Gel	NULL
slices	NULL
containing	NULL
p65	NULL
homodimers	NULL
were	NULL
irradiated	NULL
with	NULL
UV	NULL
light	NULL
in	NULL
situ	NULL
and	NULL
excised	NULL
,	NULL
and	NULL
radiolabeled	NULL
adducts	NULL
were	NULL
either	NULL
resolved	NULL
directly	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
or	NULL
eluted	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
a	NULL
p65-specific	NULL
antiserum	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
7	NULL
)	NULL
.	NULL

A	NULL
gel	NULL
slice	NULL
containing	NULL
p65-p50	NULL
heterodimers	NULL
from	NULL
PMA-stimulated	NULL
Jurkat	NULL
nuclear	NULL
extracts	NULL
was	NULL
analyzed	NULL
in	NULL
lane	NULL
4	NULL
.	NULL

UV-cross-linked	NULL
p65-DNA	NULL
and	NULL
p50-DNA	NULL
adducts	NULL
are	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
lanes	NULL
7	NULL
and	NULL
10	NULL
)	NULL
or	NULL
anti-p50	NULL
(	NULL
lanes	NULL
9	NULL
and	NULL
12	NULL
)	NULL
antiserum	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
this	NULL
novel	NULL
p6S5-associated	NULL
complex	NULL
failed	NULL
to	NULL
react	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
monospecific	NULL
antipeptide	NULL
antisera	NULL
raised	NULL
against	NULL
other	NULL
known	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B-Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
p52	NULL
(	NULL
14	NULL
,	NULL
48	NULL
,	NULL
59	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
RelB	NULL
(	NULL
56	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
when	NULL
these	NULL
putative	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
p65	NULL
complexes	NULL
were	NULL
cross-linked	NULL
in	NULL
situ	NULL
with	NULL
UV	NULL
light	NULL
to	NULL
a	NULL
*2P-labeled	NULL
xB	NULL
enhancer	NULL
probe	NULL
and	NULL
the	NULL
specific	NULL
complexes	NULL
were	NULL
isolated	NULL
,	NULL
a	NULL
single	NULL
photoreactive	NULL
adduct	NULL
of	NULL
~72	NULL
kDa	NULL
was	NULL
detected	NULL
following	NULL
SDS-PAGE	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
adduct	NULL
comigrated	NULL
with	NULL
authentic	NULL
p6S-DNA	NULL
adducts	NULL
derived	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
which	NULL
migrate	NULL
as	NULL
a	NULL
slightly	NULL
larger	NULL
species	NULL
relative	NULL
to	NULL
native	NULL
p65	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
cross-linked	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
the	NULL
more	NULL
rapidly	NULL
migrating	NULL
pS50-p65	NULL
com	NULL
plexes	NULL
were	NULL
cross-linked	NULL
,	NULL
both	NULL
p50	NULL
and	NULL
p65	NULL
species	NULL
were	NULL
identified	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
results	NULL
,	NULL
a	NULL
single	NULL
°P-	NULL
radiolabeled	NULL
adduct	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
was	NULL
specifically	NULL
immunoprecipitated	NULL
with	NULL
p65-specific	NULL
antiserum	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
thus	NULL
confirming	NULL
the	NULL
presence	NULL
of	NULL
p65	NULL
epitopes	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
findings	NULL
strongly	NULL
suggest	NULL
that	NULL
inactive	NULL
but	NULL
inducible	NULL
p65	NULL
homodimers	NULL
exist	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
nonstimulated	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Sequences	NULL
mediating	NULL
p65	NULL
homodimer	NULL
formation	NULL
are	NULL
contained	NULL
within	NULL
the	NULL
IxBax	NULL
binding	NULL
domain	NULL
.	NULL

In	NULL
order	NULL
to	NULL
delineate	NULL
the	NULL
intrinsic	NULL
sequences	NULL
that	NULL
mediate	NULL
p65	NULL
homodimerization	NULL
,	NULL
a	NULL
series	NULL
of	NULL
C-terminal	NULL
deletions	NULL
was	NULL
introduced	NULL
into	NULL
the	NULL
full-length	NULL
human	NULL
p65	NULL
cDNA	NULL
.	NULL

Monkey	NULL
COS	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
recombinant	NULL
expression	NULL
vectors	NULL
containing	NULL
these	NULL
truncated	NULL
cDNAs	NULL
together	NULL
with	NULL
a	NULL
full-length	NULL
wild-type	NULL
p65	NULL
construct	NULL
and	NULL
metabolically	NULL
radiolabeled	NULL
with	NULL
both	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
97	NULL
-43-	NULL
f	NULL
Wit	NULL
|	NULL
»	NULL
-	NULL
<	NULL
lcBe	NULL
2	NULL
Lo	NULL
.	NULL

2	NULL
,	NULL
2	NULL
A	NULL
A	NULL
2	NULL
,	NULL
As	NULL
.	NULL

2	NULL
2	NULL
2	NULL
,	NULL
A	NULL
5	NULL
*	NULL
%	NULL
*~	NULL
``	NULL
a	NULL
``	NULL
m	NULL
~A	NULL
a	NULL
,	NULL
.	NULL

``	NULL
&	NULL
.	NULL

~a	NULL
a	NULL
,	NULL
h	NULL
547394-	NULL
JL	NULL
.	NULL

JL	NULL
TJ	NULL
64	NULL
)	NULL
%	NULL
b	NULL
.	NULL

*L.	NULL
&	NULL
.	NULL

4	NULL
S	NULL
34	NULL
``	NULL
3	NULL
*	NULL
,	NULL
%	NULL
%	NULL
5	NULL
*	NULL
%	NULL
*A	NULL
``	NULL
%	NULL
*	NULL
%	NULL
A	NULL
7	NULL
/	NULL
A	NULL
z	NULL
30	NULL
$	NULL
2	NULL
}	NULL
59	NULL
«	NULL
79	NULL
~~	NULL
sp65	NULL
WT	NULL
.	NULL

+p65	NULL
WT	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

The	NULL
homodimerization	NULL
domain	NULL
of	NULL
p65	NULL
corresponds	NULL
to	NULL
a	NULL
sequence	NULL
of	NULL
91	NULL
amino	NULL
acids	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
.	NULL

``	NULL
S-labeled	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
full-length	NULL
p65	NULL
in	NULL
combination	NULL
with	NULL
the	NULL
indicated	NULL
C-terminally	NULL
(	NULL
A	NULL
)	NULL
or	NULL
N-terminally	NULL
(	NULL
B	NULL
)	NULL
truncated	NULL
p65	NULL
mutants	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
using	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
(	NULL
A	NULL
)	NULL
or	NULL
N	NULL
(	NULL
B	NULL
)	NULL
terminus	NULL
of	NULL
p65	NULL
.	NULL

Immunoreactive	NULL
complexes	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
full-length	NULL
p65	NULL
(	NULL
WT	NULL
)	NULL
and	NULL
endogenous	NULL
IxBa	NULL
(	NULL
IxB	NULL
,	NULL
)	NULL
.	NULL

[	NULL
*SJcysteine	NULL
and	NULL
[	NULL
**SJmethionine	NULL
,	NULL
and	NULL
then	NULL
whole-cell	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
an	NULL
antipeptide	NULL
antiserum	NULL
raised	NULL
against	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
535	NULL
to	NULL
551	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
this	NULL
antibody	NULL
reacted	NULL
specifically	NULL
with	NULL
a	NULL
radiolabeled	NULL
65-	NULL
to	NULL
72-kDa	NULL
polypeptide	NULL
present	NULL
in	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
full-length	NULL
p65	NULL
expression	NULL
vector	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
in	NULL
COS	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
parental	NULL
pCMV4	NULL
expression	NULL
vector	NULL
lacking	NULL
a	NULL
cDNA	NULL
insert	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

When	NULL
cDNAs	NULL
encoding	NULL
the	NULL
C-terminal	NULL
truncation	NULL
mutants	NULL
of	NULL
p65	NULL
were	NULL
cotransfected	NULL
with	NULL
wild-type	NULL
p65	NULL
,	NULL
many	NULL
of	NULL
the	NULL
smaller	NULL
radiolabeled	NULL
proteins	NULL
lacking	NULL
the	NULL
antibody	NULL
epitope	NULL
were	NULL
coimmunoprecipitated	NULL
,	NULL
indicating	NULL
the	NULL
formation	NULL
of	NULL
stable	NULL
homodimeric	NULL
complexes	NULL
between	NULL
the	NULL
full-length	NULL
and	NULL
truncated	NULL
p65	NULL
proteins	NULL
.	NULL

Specifically	NULL
,	NULL
progressive	NULL
deletions	NULL
that	NULL
removed	NULL
the	NULL
p65	NULL
transactivation	NULL
domain	NULL
(	NULL
amino	NULL
acids	NULL
450-551	NULL
;	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
(	NULL
8	NULL
,	NULL
57	NULL
,	NULL
60	NULL
)	NULL
,	NULL
the	NULL
mini-leucine	NULL
zipper	NULL
(	NULL
amino	NULL
acids	NULL
436	NULL
to	NULL
450	NULL
;	NULL
lane	NULL
4	NULL
)	NULL
(	NULL
57	NULL
)	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
amino	NULL
acids	NULL
301	NULL
to	NULL
304	NULL
;	NULL
lane	NULL
5	NULL
)	NULL
(	NULL
11	NULL
,	NULL
21	NULL
)	NULL
did	NULL
not	NULL
disrupt	NULL
homodimerization	NULL
.	NULL

However	NULL
,	NULL
further	NULL
deletion	NULL
to	NULL
amino	NULL
acid	NULL
270	NULL
,	NULL
which	NULL
ablates	NULL
a	NULL
consensus	NULL
recognition	NULL
site	NULL
for	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
amino	NULL
acids	NULL
272	NULL
to	NULL
276	NULL
;	NULL
RRPS	NULL
)	NULL
(	NULL
35	NULL
)	NULL
completely	NULL
disrupted	NULL
this	NULL
function	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Immunoblot	NULL
analyses	NULL
of	NULL
all	NULL
extracts	NULL
used	NULL
in	NULL
these	NULL
experiments	NULL
confirmed	NULL
that	NULL
the	NULL
vectors	NULL
encoding	NULL
these	NULL
truncated	NULL
mutants	NULL
expressed	NULL
comparable	NULL
amounts	NULL
of	NULL
the	NULL
relevant	NULL
protein	NULL
species	NULL
,	NULL
including	NULL
the	NULL
p65	NULL
(	NULL
1-270	NULL
)	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
localize	NULL
the	NULL
C-terminal	NULL
limits	NULL
of	NULL
the	NULL
p65	NULL
homodimerization	NULL
domain	NULL
to	NULL
a	NULL
segment	NULL
between	NULL
amino	NULL
acids	NULL
270	NULL
and	NULL
291	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
this	NULL
boundary	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
C-terminal	NULL
boundary	NULL
for	NULL
IxBa	NULL
binding	NULL
but	NULL
is	NULL
coincident	NULL
with	NULL
that	NULL
required	NULL
for	NULL
p65	NULL
DNA	NULL
binding	NULL
,	NULL
a	NULL
function	NULL
that	NULL
appears	NULL
to	NULL
be	NULL
strictly	NULL
dependent	NULL
on	NULL
dimer	NULL
formation	NULL
(	NULL
21	NULL
)	NULL
.	NULL

In	NULL
reciprocal	NULL
studies	NULL
,	NULL
cDNAs	NULL
encoding	NULL
a	NULL
series	NULL
of	NULL
N-terminal	NULL
deletion	NULL
mutants	NULL
of	NULL
p65	NULL
were	NULL
expressed	NULL
in	NULL
COS	NULL
cells	NULL
HOMODIMERIZATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
7829	NULL
together	NULL
with	NULL
full-length	NULL
p65	NULL
.	NULL

Radiolabeled	NULL
whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
these	NULL
cells	NULL
and	NULL
subjected	NULL
to	NULL
coimmunoprecipitation	NULL
analyses	NULL
with	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
unique	NULL
N	NULL
terminus	NULL
of	NULL
p65	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
21	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
truncated	NULL
mutants	NULL
of	NULL
p65	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
lacking	NULL
up	NULL
to	NULL
200	NULL
N-terminal	NULL
amino	NULL
acids	NULL
were	NULL
readily	NULL
coimmunoprecipitated	NULL
with	NULL
the	NULL
full-length	NULL
protein	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
proximal	NULL
two-thirds	NULL
of	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
are	NULL
dispensable	NULL
for	NULL
the	NULL
homodimerization	NULL
function	NULL
of	NULL
p65	NULL
.	NULL

However	NULL
,	NULL
removal	NULL
of	NULL
an	NULL
additional	NULL
50	NULL
amino	NULL
acids	NULL
containing	NULL
a	NULL
highly	NULL
conserved	NULL
cysteine	NULL
residue	NULL
(	NULL
Cys-216	NULL
;	NULL
see	NULL
below	NULL
)	NULL
completely	NULL
disrupted	NULL
homodimer	NULL
formation	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

These	NULL
bidirectional	NULL
deletion	NULL
mapping	NULL
studies	NULL
thus	NULL
established	NULL
that	NULL
the	NULL
maximal	NULL
boundaries	NULL
of	NULL
the	NULL
p65	NULL
homodimerization	NULL
domain	NULL
lie	NULL
between	NULL
amino	NULL
acids	NULL
201	NULL
and	NULL
291	NULL
,	NULL
a	NULL
segment	NULL
positioned	NULL
within	NULL
Rel	NULL
homology	NULL
sequences	NULL
that	NULL
also	NULL
mediates	NULL
the	NULL
IxBa	NULL
and	NULL
DNA	NULL
binding	NULL
functions	NULL
of	NULL
this	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
(	NULL
11	NULL
,	NULL
21	NULL
,	NULL
50	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
these	NULL
truncation	NULL
mutants	NULL
were	NULL
cotransfected	NULL
with	NULL
p50	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
homo-	NULL
and	NULL
heterodimerization	NULL
domains	NULL
of	NULL
p65	NULL
are	NULL
either	NULL
coincident	NULL
or	NULL
significantly	NULL
overlapping	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Two	NULL
distinct	NULL
classes	NULL
of	NULL
point	NULL
mutations	NULL
within	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
p65	NULL
segregate	NULL
its	NULL
homo-	NULL
and	NULL
heterodimerization	NULL
functions	NULL
.	NULL

Biochemical	NULL
studies	NULL
with	NULL
purified	NULL
p65	NULL
suggest	NULL
that	NULL
this	NULL
subunit	NULL
engages	NULL
its	NULL
cognate	NULL
enhancer	NULL
as	NULL
.	NULL

a	NULL
homodimer	NULL
,	NULL
presumably	NULL
reflecting	NULL
a	NULL
requirement	NULL
for	NULL
the	NULL
apposition	NULL
of	NULL
certain	NULL
key	NULL
amino	NULL
acids	NULL
from	NULL
each	NULL
monomer	NULL
to	NULL
form	NULL
a	NULL
functional	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
NF-	NULL
«	NULL
xB	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
vitro	NULL
is	NULL
potently	NULL
inhibited	NULL
by	NULL
sufhydryl	NULL
and	NULL
oxidizing	NULL
agents	NULL
(	NULL
37	NULL
,	NULL
43	NULL
,	NULL
66	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
Toledana	NULL
et	NULL
al	NULL
.	NULL

(	NULL
66	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
cysteine	NULL
62	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
is	NULL
critically	NULL
involved	NULL
in	NULL
mediating	NULL
these	NULL
redox	NULL
effects	NULL
.	NULL

Inspection	NULL
of	NULL
the	NULL
predicted	NULL
p65	NULL
primary	NULL
sequence	NULL
(	NULL
55	NULL
)	NULL
revealed	NULL
a	NULL
total	NULL
of	NULL
nine	NULL
cysteine	NULL
residues	NULL
that	NULL
are	NULL
exclusively	NULL
clustered	NULL
in	NULL
the	NULL
Rel	NULL
homology/DNA	NULL
binding	NULL
domain	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

Six	NULL
of	NULL
these	NULL
cysteine	NULL
residues	NULL
are	NULL
highly	NULL
conserved	NULL
among	NULL
all	NULL
other	NULL
known	NULL
Rel-related	NULL
proteins	NULL
(	NULL
25	NULL
,	NULL
55	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
functional	NULL
and	NULL
structural	NULL
consider-ations	NULL
,	NULL
each	NULL
of	NULL
the	NULL
six	NULL
highly	NULL
conserved	NULL
p65	NULL
cysteines	NULL
was	NULL
replaced	NULL
with	NULL
serine	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
mutants	NULL
were	NULL
assessed	NULL
for	NULL
changes	NULL
in	NULL
p6S	NULL
DNA	NULL
binding	NULL
activity	NULL
and	NULL
homodimer	NULL
formation	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
each	NULL
of	NULL
these	NULL
full-length	NULL
p65	NULL
mutants	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
IxBa	NULL
were	NULL
first	NULL
analyzed	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
a	NULL
*°P-labeled	NULL
kB	NULL
enhancer	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
in	NULL
vivo-synthe-sized	NULL
p65	NULL
supported	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
distinct	NULL
nucleoprotein	NULL
complex	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
which	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
coexpression	NULL
with	NULL
IkBa	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

This	NULL
wild-type	NULL
pattern	NULL
of	NULL
IxBo-regulated	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
fully	NULL
recapitulated	NULL
by	NULL
cysteine	NULL
mutants	NULL
altered	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
95	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
,	NULL
160	NULL
(	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
,	NULL
and	NULL
197	NULL
(	NULL
lanes	NULL
13	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
results	NULL
reported	NULL
for	NULL
v-Rel	NULL
(	NULL
37	NULL
)	NULL
,	NULL
substitution	NULL
of	NULL
serine	NULL
for	NULL
conserved	NULL
cysteine	NULL
38	NULL
produced	NULL
modestly	NULL
enhanced	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
point	NULL
mutations	NULL
introduced	NULL
into	NULL
p65	NULL
at	NULL
residues	NULL
120	NULL
(	NULL
C-120-	NULL
>	NULL
S	NULL
[	NULL
C120S	NULL
]	NULL
;	NULL
lane	NULL
9	NULL
)	NULL
and	NULL
216	NULL
(	NULL
C216S	NULL
;	NULL
lane	NULL
15	NULL
)	NULL
significantly	NULL
attenuated	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
p65	NULL
,	NULL
although	NULL
Western	NULL
blot	NULL
analyses	NULL
indicated	NULL
comparable	NULL
levels	NULL
of	NULL
protein	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
five	NULL
of	NULL
these	NULL
six	NULL
highly	NULL
conserved	NULL
cysteine	NULL
residues	NULL
are	NULL
positioned	NULL
outside	NULL
the	NULL
homodimerization	NULL
domain	NULL
as	NULL
localized	NULL
by	NULL
deletion	NULL
mapping	NULL
.	NULL

Only	NULL
cysteine	NULL
216	NULL
is	NULL
present	NULL
within	NULL
this	NULL
critical	NULL
subregion	NULL
.	NULL

Thus	NULL
,	NULL
one	NULL
plausible	NULL
mechanistic	NULL
explanation	NULL
for	NULL
these	NULL
DNA	NULL
7830	NULL
GANCHI	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

atio	NULL
COOH	NULL
PKA	NULL
NLS	NULL
A	NULL
(	NULL
RRPS	NULL
)	NULL
_	NULL
(	NULL
KRKR	NULL
)	NULL
MLZ	NULL
NP	NULL
Eli	NULL
Rel	NULL
Homology	NULL
Domain	NULL
T	NULL
|	NULL
1	NULL
100	NULL
(	NULL
L716	NULL
00	NULL
2	NULL
Dimerization	NULL
IxB	NULL
Binding	NULL
DNA	NULL
Binding	NULL
12	NULL
``	NULL
3	NULL
4	NULL
56	NULL
T	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
p6S/p65	NULL
~	NULL
IKB	NULL
:	NULL
=	NULL
-	NULL
4	NULL
%	NULL
-	NULL
%	NULL
-	NULL
#	NULL
0	NULL
-	NULL
#	NULL
-	NULL
%	NULL
-	NULL
%	NULL
0	NULL
As	NULL
a	NULL
a	NULL
a	NULL
y	NULL
a	NULL
9	NULL
A	NULL
3/1	NULL
?	NULL

p	NULL
%	NULL
09	NULL
``	NULL
3	NULL
ip	NULL
A	NULL
&	NULL
G	NULL
1-312	NULL
>	NULL
Ogownbw	NULL
a	NULL
--	NULL
SUB	NULL
-	NULL
WW	NULL
=	NULL
uae	NULL
==	NULL
we	NULL
==	NULL
wh	NULL
a	NULL
,	NULL
``	NULL
C	NULL
,	NULL
``	NULL
a	NULL
6	NULL
.	NULL

2	NULL
.	NULL

*	NULL
,	NULL
<	NULL
G	NULL
*	NULL
&	NULL
.	NULL

%	NULL
*A	NULL
+0	NULL
-	NULL
+	NULL
Wo	NULL
,	NULL
s.	NULL
G	NULL
9	NULL
t	NULL
<	NULL
e	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

A	NULL
single	NULL
highly	NULL
conserved	NULL
cysteine	NULL
located	NULL
within	NULL
the	NULL
homodimerization	NULL
domain	NULL
is	NULL
essential	NULL
for	NULL
p65	NULL
DNA	NULL
binding	NULL
and	NULL
homodimer	NULL
formation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Primary	NULL
domain	NULL
structure	NULL
of	NULL
p65	NULL
with	NULL
the	NULL
maximal	NULL
amino	NULL
acid	NULL
endpoints	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
(	NULL
amino	NULL
acids	NULL
21	NULL
to	NULL
291	NULL
)	NULL
,	NULL
IxB	NULL
binding	NULL
(	NULL
amino	NULL
acids	NULL
151	NULL
to	NULL
312	NULL
)	NULL
,	NULL
and	NULL
dimerization	NULL
(	NULL
amino	NULL
acids	NULL
201	NULL
to	NULL
291	NULL
)	NULL
domains	NULL
.	NULL

The	NULL
N-terminal	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
highly	NULL
conserved	NULL
tetrapeptide	NULL
motifs	NULL
,	NULL
a	NULL
functional	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
NLS	NULL
)	NULL
(	NULL
KRKR	NULL
;	NULL
amino	NULL
acids	NULL
301	NULL
to	NULL
304	NULL
)	NULL
and	NULL
a	NULL
consensus	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
phosphorylation	NULL
site	NULL
(	NULL
RRPS	NULL
,	NULL
amino	NULL
acids	NULL
273	NULL
to	NULL
276	NULL
)	NULL
,	NULL
is	NULL
shown	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
C-terminal	NULL
sequences	NULL
encoding	NULL
the	NULL
transcriptional	NULL
activation	NULL
domain	NULL
and	NULL
the	NULL
mini-leucine	NULL
zipper	NULL
motif	NULL
(	NULL
MLZ	NULL
)	NULL
.	NULL

The	NULL
single	NULL
highly	NULL
conserved	NULL
cysteine	NULL
residue	NULL
contained	NULL
within	NULL
the	NULL
dimerization	NULL
domain	NULL
is	NULL
also	NULL
indicated	NULL
(	NULL
C216	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Extracts	NULL
from	NULL
COS	NULL
cell	NULL
transfectants	NULL
expressing	NULL
unmodified	NULL
pCMV4	NULL
,	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
p65	NULL
,	NULL
or	NULL
the	NULL
indicated	NULL
cysteine	NULL
mutants	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
IxBa	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
radiolabeled	NULL
xB	NULL
enhancer	NULL
probe	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
native	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
homodimers	NULL
of	NULL
p65	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Full-length	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
551	NULL
;	NULL
FL	NULL
)	NULL
and	NULL
truncated	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
312	NULL
)	NULL
forms	NULL
of	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
p65	NULL
and	NULL
the	NULL
C120S	NULL
and	NULL
C216S	NULL
mutants	NULL
were	NULL
coexpressed	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
analysis	NULL
with	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
p65	NULL
.	NULL

binding	NULL
results	NULL
is	NULL
that	NULL
the	NULL
C216S	NULL
mutant	NULL
is	NULL
defective	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
homodimerize	NULL
,	NULL
a	NULL
prerequisite	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
whereas	NULL
the	NULL
C120S	NULL
mutant	NULL
lacks	NULL
an	NULL
essential	NULL
determinant	NULL
(	NULL
s	NULL
)	NULL
required	NULL
for	NULL
appropriate	NULL
contacts	NULL
with	NULL
the	NULL
«	NULL
B	NULL
enhancer	NULL
.	NULL

To	NULL
address	NULL
this	NULL
possibility	NULL
,	NULL
coimmunoprecipitation	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
radiolabeled	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
full-length	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
551	NULL
)	NULL
and	NULL
C-terminally	NULL
truncated	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
312	NULL
)	NULL
forms	NULL
of	NULL
these	NULL
mutant	NULL
p65	NULL
proteins	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
variants	NULL
lacking	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
p65	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
reactive	NULL
with	NULL
a	NULL
C-terminal	NULL
epitope	NULL
when	NULL
coexpressed	NULL
with	NULL
either	NULL
wild-type	NULL
p65	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
the	NULL
C120S	NULL
mutant	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
each	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
capable	NULL
of	NULL
forming	NULL
stable	NULL
homodimers	NULL
.	NULL

However	NULL
,	NULL
full-length	NULL
and	NULL
truncated	NULL
{	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
312	NULL
)	NULL
forms	NULL
of	NULL
p65	NULL
containing	NULL
the	NULL
C216S	NULL
mutation	NULL
failed	NULL
to	NULL
coimmunoprecipitate	NULL
,	NULL
thus	NULL
confirming	NULL
the	NULL
inability	NULL
of	NULL
this	NULL
cysteine	NULL
mutant	NULL
to	NULL
homodimerize	NULL
.	NULL

As	NULL
only	NULL
dimers	NULL
of	NULL
Rel	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
DNA	NULL
,	NULL
these	NULL
results	NULL
likely	NULL
explain	NULL
the	NULL
attenuated	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
C216S	NULL
mutant	NULL
observed	NULL
in	NULL
gel	NULL
shift	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
15	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
cysteine	NULL
216	NULL
,	NULL
the	NULL
p65	NULL
homodimerization	NULL
domain	NULL
also	NULL
contains	NULL
a	NULL
consensus	NULL
recognition	NULL
site	NULL
for	NULL
cAMP-dependent	NULL
protein	NULL
kinase	NULL
(	NULL
RRPS	NULL
;	NULL
amino	NULL
acids	NULL
273	NULL
to	NULL
276	NULL
)	NULL
(	NULL
35	NULL
)	NULL
.	NULL

Although	NULL
its	NULL
physiological	NULL
function	NULL
remains	NULL
unclear	NULL
,	NULL
this	NULL
site	NULL
is	NULL
conserved	NULL
in	NULL
almost	NULL
all	NULL
known	NULL
Rel	NULL
polypeptides	NULL
and	NULL
is	NULL
adjacent	NULL
to	NULL
a	NULL
basic	NULL
tetrapeptide	NULL
motif	NULL
that	NULL
appears	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
common	NULL
nuclear	NULL
localization	NULL
signal	NULL
for	NULL
this	NULL
transcription	NULL
factor	NULL
family	NULL
(	NULL
25	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
we	NULL
(	NULL
69	NULL
)	NULL
and	NULL
others	NULL
(	NULL
45	NULL
)	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
altering	NULL
serine	NULL
to	NULL
alanine	NULL
within	NULL
the	NULL
RRPS	NULL
motif	NULL
of	NULL
the	NULL
related	NULL
v-Rel	NULL
oncoprotein	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
its	NULL
DNA	NULL
binding	NULL
and	NULL
heterodimerization	NULL
functions	NULL
.	NULL

To	NULL
assess	NULL
whether	NULL
this	NULL
site	NULL
is	NULL
a	NULL
requisite	NULL
determinant	NULL
for	NULL
p65	NULL
DNA	NULL
binding	NULL
and/or	NULL
homodimer	NULL
formation	NULL
,	NULL
serine	NULL
276	NULL
was	NULL
substituted	NULL
with	NULL
four	NULL
distinct	NULL
amino	NULL
acids	NULL
(	NULL
RRPS-RRPA	NULL
,	NULL
RRPG	NULL
,	NULL
RRPD	NULL
,	NULL
and	NULL
RRPE	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
two	NULL
of	NULL
these	NULL
amino	NULL
acid	NULL
replacements	NULL
,	NULL
RRPD	NULL
and	NULL
RRPE	NULL
,	NULL
introduce	NULL
negatively	NULL
charged	NULL
residues	NULL
at	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
A	NULL
1	NULL
2	NULL
a	NULL
4.58	NULL
1°	NULL
_2	NULL
.	NULL

3	NULL
pésipes	NULL
>	NULL
-	NULL
@	NULL
IB	NULL
-	NULL
og	NULL
-	NULL
#	NULL
-	NULL
+	NULL
Weare	NULL
4	NULL
,	NULL
3s	NULL
632°	NULL
63940	NULL
#	NULL
y	NULL
>	NULL
1-312	NULL
x00	NULL
14,9	NULL
1129	NULL
Sq	NULL
)	NULL
404	NULL
no	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Alteration	NULL
of	NULL
the	NULL
serine	NULL
residue	NULL
within	NULL
the	NULL
conserved	NULL
consensus	NULL
RRPS	NULL
motif	NULL
of	NULL
p65	NULL
disrupts	NULL
DNA	NULL
binding	NULL
and	NULL
homodimerization	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Extracts	NULL
from	NULL
COS	NULL
transfectants	NULL
containing	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
p65	NULL
or	NULL
the	NULL
indicated	NULL
RRPS	NULL
mutants	NULL
were	NULL
assayed	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
-	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
+	NULL
)	NULL
of	NULL
IxBa	NULL
by	NULL
using	NULL
a	NULL
radiolabeled	NULL
«	NULL
kB	NULL
enhancer	NULL
probe	NULL
.	NULL

Nucleoprotein	NULL
complexes	NULL
containing	NULL
p65	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Full-length	NULL
(	NULL
FL	NULL
)	NULL
and	NULL
truncated	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
312	NULL
)	NULL
forms	NULL
of	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
p65	NULL
,	NULL
RRPA	NULL
,	NULL
and	NULL
RRPD	NULL
were	NULL
coexpressed	NULL
in	NULL
COS	NULL
cells	NULL
.	NULL

Extracts	NULL
from	NULL
S-labeled	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
an	NULL
antiserum	NULL
specific	NULL
for	NULL
the	NULL
C	NULL
terminus	NULL
of	NULL
p65	NULL
.	NULL

the	NULL
phosphate	NULL
acceptor	NULL
position	NULL
,	NULL
thus	NULL
potentially	NULL
mimicking	NULL
the	NULL
local	NULL
charge	NULL
distribution	NULL
associated	NULL
with	NULL
phosphoryla-tion	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
DNA	NULL
binding	NULL
assays	NULL
revealed	NULL
that	NULL
none	NULL
of	NULL
these	NULL
p65	NULL
mutants	NULL
formed	NULL
stable	NULL
complexes	NULL
with	NULL
the	NULL
radiolabeled	NULL
«	NULL
kB	NULL
enhancer	NULL
probe	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
and	NULL
data	NULL
not	NULL
HOMODIMERIZATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
7831	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
cotransfection	NULL
experiments	NULL
performed	NULL
with	NULL
cDNAs	NULL
encoding	NULL
full-length	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
551	NULL
)	NULL
and	NULL
truncated	NULL
(	NULL
amino	NULL
acids	NULL
1	NULL
to	NULL
312	NULL
)	NULL
forms	NULL
of	NULL
each	NULL
of	NULL
these	NULL
mutants	NULL
demonstrated	NULL
a	NULL
loss	NULL
of	NULL
homodimerization	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
all	NULL
of	NULL
these	NULL
mutants	NULL
were	NULL
stably	NULL
expressed	NULL
as	NULL
assessed	NULL
by	NULL
independent	NULL
immunoblotting	NULL
studies	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
these	NULL
RRPS	NULL
mutations	NULL
define	NULL
a	NULL
second	NULL
distinct	NULL
class	NULL
of	NULL
homodimerization-defective	NULL
variants	NULL
of	NULL
p65	NULL
that	NULL
fall	NULL
within	NULL
the	NULL
dimerization	NULL
domain	NULL
as	NULL
defined	NULL
by	NULL
deletion	NULL
mapping	NULL
studies	NULL
.	NULL

In	NULL
complementary	NULL
experiments	NULL
designed	NULL
to	NULL
assess	NULL
the	NULL
abilities	NULL
of	NULL
these	NULL
various	NULL
mutants	NULL
to	NULL
form	NULL
heterodimers	NULL
with	NULL
p50	NULL
,	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
coexpressing	NULL
each	NULL
mutant	NULL
and	NULL
p50	NULL
were	NULL
subjected	NULL
to	NULL
conmmunoprecnpltatlon	NULL
analyses	NULL
with	NULL
p6S-specific	NULL
antiserum	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
p50	NULL
and	NULL
a	NULL
smalier	NULL
N-terminal	NULL
degradation	NULL
product	NULL
of	NULL
p50	NULL
were	NULL
coimmunoprecipitated	NULL
with	NULL
wild-type	NULL
p65	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
both	NULL
the	NULL
C216S	NULL
mutant	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
the	NULL
two	NULL
RRPS	NULL
mutants	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
which	NULL
failed	NULL
to	NULL
homodimerize	NULL
efficiently	NULL
,	NULL
retained	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
p50	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
C216S	NULL
and	NULL
RRPS	NULL
p65	NULL
mutations	NULL
segregate	NULL
the	NULL
homo-	NULL
and	NULL
heterodimerization	NULL
functions	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
homodimerization	NULL
mutants	NULL
could	NULL
be	NULL
functionally	NULL
rescued	NULL
by	NULL
heterodimerization	NULL
with	NULL
p50	NULL
,	NULL
two	NULL
in	NULL
vivo	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

First	NULL
,	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
HIV-1	NULL
kB	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
expression	NULL
vectors	NULL
encoding	NULL
p50	NULL
and	NULL
each	NULL
p65	NULL
mutant	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
cotransfection	NULL
of	NULL
wild-type	NULL
p65	NULL
and	NULL
«	NULL
B-TATA-CAT	NULL
resulted	NULL
in	NULL
potent	NULL
activation	NULL
of	NULL
«	NULL
B-directed	NULL
transcription	NULL
(	NULL
~180	NULL
fold	NULL
)	NULL
compared	NULL
with	NULL
that	NULL
observed	NULL
with	NULL
either	NULL
the	NULL
unmodified	NULL
parental	NULL
expression	NULL
vector	NULL
(	NULL
pCMV4	NULL
)	NULL
or	NULL
p50	NULL
alone	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
the	NULL
C216S	NULL
mutant	NULL
and	NULL
A	NULL
P22	NULL
``	NULL
``	NULL
s	NULL
'	NULL
%	NULL
B	NULL
400	NULL
5	NULL
0	NULL
=	NULL
S	NULL
_	NULL
=	NULL
200	NULL
w.	NULL
<	NULL
65	NULL
>	NULL
p	NULL
w	NULL
:	NULL
wan	NULL
3	NULL
o	NULL
LL	NULL
oso	NULL
.	NULL

Wily	NULL
«	NULL
illy	NULL
eae	NULL
wae	NULL
8=	NULL
*	NULL
LCT	NULL
_	NULL
Aanes	NULL
C	NULL
N	NULL
X	NULL
N	NULL
N	NULL
Coa	NULL
%	NULL
.	NULL

%	NULL
n	NULL
P	NULL
3	NULL
in	NULL
.	NULL

``	NULL
B	NULL
2	NULL
4	NULL
4	NULL
*b	NULL
if	NULL
)	NULL
NIH	NULL
~Xown	NULL
yexuX®	NULL
Nw	NULL
X	NULL
Pa	NULL
,	NULL
0s	NULL
ta	NULL
4G	NULL
%	NULL
s	NULL
%	NULL
*s.	NULL
4	NULL
Po	NULL
P	NULL
Cn	NULL
J	NULL
&	NULL
,	NULL
.	NULL

%	NULL
s	NULL
3	NULL
C	NULL
,	NULL
b	NULL
.	NULL

To	NULL
P	NULL
-__	NULL
+p50	NULL
4	NULL
1:2	NULL
$	NULL
5.06	NULL
.	NULL

7.89	NULL
10	NULL
<	NULL
--	NULL
-	NULL
>	NULL
»	NULL
-	NULL
<	NULL
-lcBq	NULL
AC	NULL
%	NULL
%	NULL
940	NULL
4	NULL
#	NULL
s	NULL
``	NULL
%	NULL
+p50	NULL
004	NULL
;	NULL
q	NULL
,	NULL
Ke	NULL
99409940	NULL
,	NULL
469	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Homodimerization-defective	NULL
p6S	NULL
variants	NULL
are	NULL
functionally	NULL
rescued	NULL
by	NULL
coexpression	NULL
with	NULL
p50	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Radiolabeled	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
p50	NULL
and	NULL
the	NULL
indicated	NULL
p65	NULL
variants	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
p65-specific	NULL
antiserum	NULL
and	NULL
fractionated	NULL
by	NULL
SDS-PAGE	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
p65	NULL
and	NULL
pSO	NULL
are	NULL
as	NULL
shown	NULL
.	NULL

The	NULL
asterisk	NULL
denotes	NULL
an	NULL
N-terminal	NULL
degradation	NULL
product	NULL
of	NULL
p50	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Human	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
indicated	NULL
polypeptides	NULL
and	NULL
a	NULL
reporter	NULL
CAT	NULL
plasmid	NULL
containing	NULL
the	NULL
HIV-1	NULL
kB	NULL
enhancer	NULL
motif	NULL
(	NULL
«	NULL
B-TATA-CAT	NULL
)	NULL
.	NULL

CAT	NULL
activity	NULL
is	NULL
presented	NULL
as	NULL
fold	NULL
induction	NULL
relative	NULL
to	NULL
basal	NULL
levels	NULL
measured	NULL
with	NULL
pCMV4	NULL
lacking	NULL
a	NULL
cDNA	NULL
insert	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Whole-cell	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
the	NULL
indicated	NULL
p65	NULL
variants	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
(	NULL
+p50	NULL
)	NULL
of	NULL
p50	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
endogenous	NULL
IxBa	NULL
«	NULL
(	NULL
IxB	NULL
,	NULL
)	NULL
expression	NULL
was	NULL
assessed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
an	NULL
IxBo-specific	NULL
antiserum	NULL
,	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescense	NULL
detection	NULL
system	NULL
.	NULL

7832	NULL
GANCHI	NULL
ET	NULL
AL	NULL
.	NULL

both	NULL
RRPS	NULL
mutants	NULL
(	NULL
RRPA	NULL
and	NULL
RRPD	NULL
)	NULL
were	NULL
minimally	NULL
active	NULL
when	NULL
transfected	NULL
alone	NULL
.	NULL

However	NULL
,	NULL
when	NULL
these	NULL
p65	NULL
mutants	NULL
were	NULL
expressed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
each	NULL
mediated	NULL
significant	NULL
transcriptional	NULL
activation	NULL
(	NULL
200-	NULL
to	NULL
300-fold	NULL
)	NULL
.	NULL

To	NULL
extend	NULL
these	NULL
initial	NULL
findings	NULL
with	NULL
exogenous	NULL
CAT	NULL
reporter	NULL
plasmids	NULL
to	NULL
a	NULL
more	NULL
physiologically	NULL
relevant	NULL
setting	NULL
,	NULL
changes	NULL
in	NULL
endogenous	NULL
IxBa	NULL
protein	NULL
expression	NULL
were	NULL
monitored	NULL
by	NULL
immunoblotting	NULL
with	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
each	NULL
of	NULL
these	NULL
p65	NULL
variants	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
when	NULL
transiently	NULL
introduced	NULL
into	NULL
these	NULL
cells	NULL
,	NULL
wild-type	NULL
p65	NULL
homodimers	NULL
potently	NULL
induce	NULL
endogenous	NULL
IxBa	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
(	NULL
65	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
endogenous	NULL
IxBa	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
extracts	NULL
from	NULL
COS	NULL
cells	NULL
expressing	NULL
wild-type	NULL
p65	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
but	NULL
not	NULL
in	NULL
those	NULL
from	NULL
pCMV4-transfected	NULL
cells	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
their	NULL
impaired	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
neither	NULL
the	NULL
C216S	NULL
mutant	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
nor	NULL
the	NULL
RRPS	NULL
mutants	NULL
(	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
alone	NULL
significantly	NULL
induced	NULL
endogenous	NULL
IxBa	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
all	NULL
three	NULL
of	NULL
these	NULL
p65	NULL
constructs	NULL
were	NULL
fully	NULL
functional	NULL
when	NULL
expressed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
p50	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
)	NULL
.	NULL

Monomeric	NULL
p65	NULL
mutants	NULL
form	NULL
stable	NULL
complexes	NULL
with	NULL
IcBa	NULL
in	NULL
vivo	NULL
.	NULL

Prior	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
amino	NULL
acids	NULL
151	NULL
to	NULL
312	NULL
of	NULL
the	NULL
p65	NULL
Rel	NULL
homology	NULL
domain	NULL
confer	NULL
its	NULL
IxB	NULL
binding	NULL
function	NULL
and	NULL
contain	NULL
a	NULL
functional	NULL
nuclear	NULL
localization	NULL
signal	NULL
that	NULL
is	NULL
efficiently	NULL
masked	NULL
upon	NULL
binding	NULL
by	NULL
IxBa	NULL
(	NULL
11	NULL
,	NULL
21	NULL
)	NULL
.	NULL

The	NULL
dimerization	NULL
domain	NULL
of	NULL
p65	NULL
is	NULL
contained	NULL
entirely	NULL
within	NULL
these	NULL
sequences	NULL
required	NULL
for	NULL
IxBa	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
mutations	NULL
introduced	NULL
within	NULL
the	NULL
dimerization	NULL
domain	NULL
of	NULL
p65	NULL
may	NULL
also	NULL
affect	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
IxBa	NULL
.	NULL

To	NULL
test	NULL
this	NULL
hypothesis	NULL
,	NULL
COS	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
expression	NULL
vectors	NULL
encoding	NULL
the	NULL
wild-type	NULL
IxBa	NULL
protein	NULL
together	NULL
with	NULL
the	NULL
cysteine	NULL
216	NULL
and	NULL
RRPS	NULL
p65	NULL
mutants	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
p6S5-specific	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
IxBa	NULL
was	NULL
readily	NULL
detected	NULL
in	NULL
immu-noprecipitates	NULL
from	NULL
cells	NULL
cotransfected	NULL
with	NULL
wild-type	NULL
p65	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
,	NULL
IxBa	NULL
was	NULL
also	NULL
efficiently	NULL
coimmunoprecipitated	NULL
with	NULL
each	NULL
of	NULL
these	NULL
homodimerization-defective	NULL
mutants	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
assembly	NULL
of	NULL
p65-IxBa	NULL
complexes	NULL
in	NULL
vivo	NULL
is	NULL
not	NULL
obligately	NULL
dependent	NULL
upon	NULL
prior	NULL
dimerization	NULL
of	NULL
p65	NULL
.	NULL

DISCUSSION	NULL
The	NULL
prototypical	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
an	NULL
inducible	NULL
heterodimeric	NULL
p50-p65	NULL
complex	NULL
that	NULL
can	NULL
activate	NULL
transcription	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
genes	NULL
and	NULL
viruses	NULL
,	NULL
notably	NULL
HIV	NULL
(	NULL
25	NULL
,	NULL
39	NULL
,	NULL
46	NULL
)	NULL
.	NULL

This	NULL
p50-p65	NULL
complex	NULL
is	NULL
sequestered	NULL
within	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
because	NULL
of	NULL
its	NULL
association	NULL
with	NULL
various	NULL
inhibitors	NULL
,	NULL
including	NULL
IxBa	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
11	NULL
,	NULL
21	NULL
,	NULL
27	NULL
,	NULL
41	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Upon	NULL
cellular	NULL
stimulation	NULL
,	NULL
IxBa	NULL
is	NULL
phospho-rylated	NULL
and	NULL
rapidly	NULL
degraded	NULL
,	NULL
thereby	NULL
permitting	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
heterodimeric	NULL
NF-KB	NULL
complex	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
17	NULL
,	NULL
23	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Although	NULL
earlier	NULL
studies	NULL
suggested	NULL
that	NULL
only	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
possessed	NULL
intrinsic	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
6	NULL
)	NULL
,	NULL
subsequent	NULL
investigations	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
also	NULL
capable	NULL
of	NULL
binding	NULL
DNA	NULL
(	NULL
8	NULL
,	NULL
9	NULL
,	NULL
50	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
p65	NULL
contains	NULL
a	NULL
potent	NULL
transcriptional	NULL
activation	NULL
domain	NULL
that	NULL
is	NULL
largely	NULL
responsible	NULL
for	NULL
the	NULL
functional	NULL
effects	NULL
attributed	NULL
to	NULL
the	NULL
heterodimeric	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
(	NULL
8	NULL
,	NULL
57	NULL
,	NULL
60	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
now	NULL
well	NULL
recognized	NULL
that	NULL
p50	NULL
homodimers	NULL
(	NULL
previously	NULL
termed	NULL
KBF1	NULL
)	NULL
(	NULL
36	NULL
,	NULL
71	NULL
)	NULL
may	NULL
be	NULL
constitutively	NULL
expressed	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
intact	NULL
human	NULL
T	NULL
lymphocytes	NULL
(	NULL
20	NULL
,	NULL
34	NULL
)	NULL
.	NULL

These	NULL
p50	NULL
homodimers	NULL
function	NULL
as	NULL
specific	NULL
repressors	NULL
of	NULL
«	NULL
B-directed	NULL
transcription	NULL
,	NULL
presumably	NULL
because	NULL
of	NULL
the	NULL
ab-	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bor	NULL
.	NULL

p6Ss	NULL
>	NULL
«	NULL
ma	NULL
esis	NULL
ere	NULL
:	NULL
oan	NULL
IB	NULL
>	NULL
Ap	NULL
As	NULL
*s	NULL
As	NULL
*s	NULL
06	NULL
x0	NULL
x	NULL
4	NULL
x	NULL
‘	NULL
9	NULL
*	NULL
,	NULL
C	NULL
,	NULL
s	NULL
``	NULL
D	NULL
,	NULL
76:9	NULL
%	NULL
*3	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Monomeric	NULL
mutants	NULL
of	NULL
p65	NULL
that	NULL
fail	NULL
to	NULL
homodimerize	NULL
are	NULL
fully	NULL
capable	NULL
of	NULL
engaging	NULL
IxBa	NULL
.	NULL

Extracts	NULL
from	NULL
COS	NULL
cells	NULL
coexpressing	NULL
IxBa	NULL
together	NULL
with	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
p65	NULL
or	NULL
the	NULL
indicated	NULL
p65	NULL
variants	NULL
were	NULL
subjected	NULL
to	NULL
coimmunoprecipitation	NULL
analysis	NULL
using	NULL
p65-specific	NULL
antiserum	NULL
.	NULL

Control	NULL
extracts	NULL
from	NULL
cells	NULL
transfected	NULL
with	NULL
IxBa	NULL
expression	NULL
vector	NULL
alone	NULL
were	NULL
analyzed	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
relative	NULL
positions	NULL
of	NULL
*°S-labeled	NULL
p65	NULL
and	NULL
IxBa	NULL
.	NULL

sence	NULL
of	NULL
a	NULL
strong	NULL
transactivation	NULL
domain	NULL
(	NULL
20	NULL
,	NULL
34	NULL
,	NULL
60	NULL
)	NULL
.	NULL

These	NULL
repressive	NULL
effects	NULL
exerted	NULL
by	NULL
p50	NULL
can	NULL
be	NULL
specifically	NULL
relieved	NULL
by	NULL
the	NULL
bei-3	NULL
proto-oncogene	NULL
product	NULL
(	NULL
20	NULL
,	NULL
28	NULL
,	NULL
51	NULL
,	NULL
70	NULL
)	NULL
,	NULL
an	NULL
IxB-like	NULL
protein	NULL
that	NULL
preferentially	NULL
reacts	NULL
with	NULL
p50	NULL
homodimers	NULL
.	NULL

However	NULL
,	NULL
the	NULL
physiological	NULL
significance	NULL
of	NULL
the	NULL
positive	NULL
transcriptional	NULL
effects	NULL
observed	NULL
with	NULL
transfected	NULL
p65	NULL
cDNAs	NULL
has	NULL
remained	NULL
unclear	NULL
,	NULL
primarily	NULL
because	NULL
evidence	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
endogenous	NULL
p65	NULL
homodimers	NULL
in	NULL
vivo	NULL
has	NULL
been	NULL
lacking	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
«	NULL
B-specific	NULL
p65	NULL
homodimers	NULL
in	NULL
nontransfected	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
formally	NULL
proven	NULL
that	NULL
this	NULL
DNA-binding	NULL
species	NULL
is	NULL
transcriptionally	NULL
active	NULL
in	NULL
a	NULL
physiologic	NULL
context	NULL
.	NULL

However	NULL
,	NULL
by	NULL
analogy	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
pS50-p65	NULL
(	NULL
6	NULL
)	NULL
,	NULL
this	NULL
homodimeric	NULL
form	NULL
of	NULL
p65	NULL
is	NULL
located	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
nonstimulated	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
detergent-sensitive	NULL
complex	NULL
,	NULL
presumably	NULL
reflecting	NULL
its	NULL
stable	NULL
association	NULL
with	NULL
IxBa	NULL
or	NULL
possibly	NULL
other	NULL
IxB-like	NULL
molecules	NULL
(	NULL
6	NULL
,	NULL
11	NULL
,	NULL
21	NULL
,	NULL
27	NULL
,	NULL
41	NULL
,	NULL
54	NULL
)	NULL
.	NULL

Independent	NULL
experimental	NULL
support	NULL
for	NULL
the	NULL
association	NULL
of	NULL
IxBa	NULL
with	NULL
p65	NULL
homodimers	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
human	NULL
HeLa	NULL
cells	NULL
has	NULL
recently	NULL
been	NULL
assembled	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Upon	NULL
cellular	NULL
stimulation	NULL
with	NULL
PMA	NULL
,	NULL
an	NULL
agent	NULL
known	NULL
to	NULL
induce	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
(	NULL
5	NULL
,	NULL
12	NULL
,	NULL
62	NULL
)	NULL
,	NULL
p65	NULL
homodimers	NULL
rapidly	NULL
move	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
are	NULL
detected	NULL
as	NULL
a	NULL
distinct	NULL
DNA-binding	NULL
species	NULL
in	NULL
gel	NULL
retardation	NULL
assays	NULL
.	NULL

Coupled	NULL
with	NULL
prior	NULL
functional	NULL
transfection	NULL
studies	NULL
(	NULL
8	NULL
,	NULL
38	NULL
,	NULL
57	NULL
,	NULL
60	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
under	NULL
certain	NULL
physiologic	NULL
conditions	NULL
the	NULL
p65	NULL
homodimer	NULL
may	NULL
be	NULL
an	NULL
I	NULL
«	NULL
xBa-regulated	NULL
transcription	NULL
factor	NULL
in	NULL
its	NULL
own	NULL
right	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
p65	NULL
to	NULL
form	NULL
either	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
in	NULL
vivo	NULL
introduces	NULL
a	NULL
flexible	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
control	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B-Rel	NULL
transcription	NULL
factor	NULL
family	NULL
.	NULL

Indeed	NULL
,	NULL
prior	NULL
transfection	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
p65	NULL
homodimers	NULL
can	NULL
stimulate	NULL
transcription	NULL
from	NULL
certain	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
enhancer	NULL
motifs	NULL
that	NULL
are	NULL
not	NULL
appreciably	NULL
recognized	NULL
by	NULL
either	NULL
p50	NULL
homodimers	NULL
or	NULL
NF-	NULL
«	NULL
B	NULL
p50-p65	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Given	NULL
such	NULL
discernible	NULL
differences	NULL
in	NULL
their	NULL
sequence	NULL
specificities	NULL
,	NULL
it	NULL
seems	NULL
likely	NULL
that	NULL
these	NULL
various	NULL
Rel	NULL
subunit	NULL
combinations	NULL
may	NULL
serve	NULL
to	NULL
selectively	NULL
regulate	NULL
the	NULL
expression	NULL
of	NULL
distinct	NULL
subsets	NULL
of	NULL
cellular	NULL
genes	NULL
(	NULL
53	NULL
)	NULL
.	NULL

The	NULL
clearly	NULL
divergent	NULL
transcriptional	NULL
activities	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
homodimers	NULL
,	NULL
as	NULL
well	NULL
as	NULL
emerging	NULL
evidence	NULL
for	NULL
their	NULL
regulation	NULL
by	NULL
distinct	NULL
IxB-like	NULL
inhibitors	NULL
(	NULL
20	NULL
,	NULL
28	NULL
,	NULL
51	NULL
,	NULL
70	NULL
)	NULL
,	NULL
suggest	NULL
that	NULL
this	NULL
potential	NULL
mechanism	NULL
for	NULL
differential	NULL
expression	NULL
of	NULL
«	NULL
B-directed	NULL
transcription	NULL
may	NULL
be	NULL
regulated	NULL
within	NULL
the	NULL
cell	NULL
at	NULL
several	NULL
distinctive	NULL
levels	NULL
.	NULL

The	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
p65	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
multiple	NULL
biological	NULL
functions	NULL
of	NULL
this	NULL
particular	NULL
transcription	NULL
factor	NULL
,	NULL
including	NULL
its	NULL
interactions	NULL
with	NULL
DNA	NULL
enhancer	NULL
elements	NULL
,	NULL
IxB	NULL
,	NULL
and	NULL
other	NULL
Rel	NULL
protein	NULL
family	NULL
members	NULL
(	NULL
8	NULL
,	NULL
11	NULL
,	NULL
21	NULL
,	NULL
25	NULL
,	NULL
50	NULL
,	NULL
55	NULL
,	NULL
60	NULL
)	NULL
.	NULL

In	NULL
light	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
select	NULL
deletions	NULL
and	NULL
point	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
this	NULL
N-terminal	NULL
homology	NULL
sequence	NULL
to	NULL
explore	NULL
the	NULL
structural	NULL
basis	NULL
for	NULL
endogenous	NULL
p65	NULL
homodimer	NULL
formation	NULL
,	NULL
an	NULL
event	NULL
that	NULL
is	NULL
necessary	NULL
to	NULL
form	NULL
a	NULL
functional	NULL
p65	NULL
DNA	NULL
binding	NULL
domain	NULL
.	NULL

Phenotypic	NULL
studies	NULL
with	NULL
these	NULL
mutants	NULL
revealed	NULL
that	NULL
the	NULL
region	NULL
conferring	NULL
p65	NULL
dimerization	NULL
corresponds	NULL
to	NULL
a	NULL
stretch	NULL
of	NULL
91	NULL
amino	NULL
acids	NULL
that	NULL
is	NULL
nested	NULL
within	NULL
Rel	NULL
homology	NULL
sequences	NULL
requisite	NULL
for	NULL
IxB	NULL
binding	NULL
.	NULL

Of	NULL
note	NULL
,	NULL
the	NULL
corresponding	NULL
region	NULL
in	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
amino	NULL
acids	NULL
256	NULL
to	NULL
351	NULL
)	NULL
has	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
het-erodimerize	NULL
with	NULL
other	NULL
Rel-related	NULL
factors	NULL
(	NULL
16	NULL
)	NULL
.	NULL

However	NULL
,	NULL
point	NULL
mutations	NULL
that	NULL
altered	NULL
a	NULL
highly	NULL
conserved	NULL
cysteine	NULL
residue	NULL
(	NULL
C216-	NULL
$	NULL
)	NULL
and	NULL
a	NULL
consensus	NULL
protein	NULL
kinase	NULL
A	NULL
recognition	NULL
site	NULL
(	NULL
RRPS-RRPA	NULL
,	NULL
RRPG	NULL
,	NULL
RRPD	NULL
,	NULL
or	NULL
RRPE	NULL
)	NULL
within	NULL
the	NULL
p65	NULL
dimerization	NULL
domain	NULL
selectively	NULL
disrupted	NULL
homodimerization	NULL
and	NULL
attenuated	NULL
DNA	NULL
binding	NULL
but	NULL
had	NULL
no	NULL
effects	NULL
on	NULL
heterodimerization	NULL
with	NULL
p50	NULL
.	NULL

As	NULL
such	NULL
,	NULL
mutations	NULL
at	NULL
these	NULL
sites	NULL
may	NULL
induce	NULL
subtle	NULL
conformational	NULL
changes	NULL
in	NULL
p65	NULL
that	NULL
differentially	NULL
affect	NULL
these	NULL
related	NULL
functions	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
novel	NULL
phenotypic	NULL
properties	NULL
,	NULL
the	NULL
transactivation	NULL
function	NULL
of	NULL
these	NULL
homodimerization-deficient	NULL
mutants	NULL
was	NULL
completely	NULL
rescued	NULL
by	NULL
coexpression	NULL
with	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Unexpectedly	NULL
,	NULL
we	NULL
have	NULL
also	NULL
found	NULL
that	NULL
these	NULL
two	NULL
distinct	NULL
classes	NULL
of	NULL
homodimerization	NULL
mutants	NULL
retained	NULL
their	NULL
abilities	NULL
to	NULL
interact	NULL
stably	NULL
with	NULL
IxBa	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
related	NULL
studies	NULL
,	NULL
Ruben	NULL
et	NULL
al	NULL
.	NULL

(	NULL
57	NULL
)	NULL
recently	NULL
observed	NULL
a	NULL
natural	NULL
splice	NULL
variant	NULL
of	NULL
p65	NULL
(	NULL
p65	NULL
)	NULL
lacking	NULL
amino	NULL
acids	NULL
222	NULL
to	NULL
231	NULL
of	NULL
its	NULL
Rel	NULL
homology	NULL
domain	NULL
,	NULL
which	NULL
fails	NULL
both	NULL
to	NULL
dimerize	NULL
and	NULL
to	NULL
bind	NULL
IxBa	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
investigators	NULL
have	NULL
concluded	NULL
that	NULL
p65	NULL
dimerization	NULL
may	NULL
be	NULL
required	NULL
to	NULL
form	NULL
a	NULL
high-affinity	NULL
IxBa	NULL
binding	NULL
site	NULL
(	NULL
11	NULL
)	NULL
,	NULL
the	NULL
present	NULL
study	NULL
suggests	NULL
that	NULL
the	NULL
lesion	NULL
in	NULL
p6SA	NULL
may	NULL
in	NULL
fact	NULL
affect	NULL
critical	NULL
sequences	NULL
within	NULL
both	NULL
the	NULL
dimerization	NULL
and	NULL
IxBa	NULL
binding	NULL
domains	NULL
of	NULL
p65	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
phenotypic	NULL
properties	NULL
of	NULL
p65SA	NULL
,	NULL
mutations	NULL
introduced	NULL
at	NULL
cysteine	NULL
216	NULL
and	NULL
within	NULL
the	NULL
conserved	NULL
protein	NULL
kinase	NULL
A	NULL
phosphorylation	NULL
site	NULL
segregate	NULL
these	NULL
two	NULL
functions	NULL
and	NULL
demonstrate	NULL
that	NULL
p65	NULL
homodimer	NULL
formation	NULL
is	NULL
not	NULL
an	NULL
obligatory	NULL
event	NULL
for	NULL
subsequent	NULL
recognition	NULL
by	NULL
IxBa	NULL
.	NULL

Furthermore	NULL
,	NULL
immunofluorescence	NULL
studies	NULL
performed	NULL
with	NULL
transfected	NULL
COS	NULL
cells	NULL
have	NULL
indicated	NULL
that	NULL
the	NULL
in	NULL
vivo	NULL
interactions	NULL
between	NULL
IxBa	NULL
and	NULL
these	NULL
monomeric	NULL
p65	NULL
variants	NULL
are	NULL
func-tional	NULL
,	NULL
as	NULL
they	NULL
lead	NULL
to	NULL
efficient	NULL
p65	NULL
retargeting	NULL
to	NULL
the	NULL
cytoplasmic	NULL
compartment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
p65	NULL
monomers	NULL
can	NULL
act	NULL
as	NULL
receptors	NULL
for	NULL
IxBa	NULL
,	NULL
as	NULL
well	NULL
as	NULL
for	NULL
other	NULL
accessory	NULL
proteins	NULL
that	NULL
facilitate	NULL
p65	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
following	NULL
IxBa	NULL
release	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
the	NULL
p65	NULL
dimerization	NULL
and	NULL
IxBa	NULL
binding	NULL
domains	NULL
physically	NULL
overlap	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
ability	NULL
of	NULL
IxBa	NULL
HOMODIMERIZATION	NULL
OF	NULL
NF-kB	NULL
p65	NULL
7833	NULL
to	NULL
bind	NULL
p65	NULL
monomers	NULL
,	NULL
raises	NULL
new	NULL
questions	NULL
concerning	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
IxBa	NULL
action	NULL
.	NULL

Specifically	NULL
,	NULL
although	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
demonstrated	NULL
that	NULL
monomeric	NULL
p65-IkBa	NULL
complexes	NULL
exist	NULL
in	NULL
vivo	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
IxBa	NULL
may	NULL
regulate	NULL
p65	NULL
not	NULL
only	NULL
by	NULL
functionally	NULL
masking	NULL
its	NULL
nuclear	NULL
localization	NULL
signal	NULL
but	NULL
also	NULL
by	NULL
interfering	NULL
with	NULL
one	NULL
or	NULL
more	NULL
structural	NULL
determinants	NULL
required	NULL
for	NULL
p65	NULL
homodimer	NULL
or	NULL
heterodimer	NULL
formation	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
the	NULL
p65	NULL
RRPS	NULL
motif	NULL
and	NULL
cysteine	NULL
216	NULL
may	NULL
selectively	NULL
impose	NULL
either	NULL
general	NULL
or	NULL
localized	NULL
structural	NULL
constraints	NULL
on	NULL
the	NULL
p65	NULL
homodimerization	NULL
domain	NULL
that	NULL
are	NULL
required	NULL
for	NULL
its	NULL
functional	NULL
integrity	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
biogenesis	NULL
of	NULL
p65	NULL
homodimers	NULL
could	NULL
conceivably	NULL
be	NULL
influenced	NULL
by	NULL
regulatory	NULL
phosphorylation	NULL
events	NULL
that	NULL
affect	NULL
the	NULL
p65	NULL
RRPS	NULL
motif	NULL
or	NULL
by	NULL
changes	NULL
in	NULL
the	NULL
intracellular	NULL
redox	NULL
potential	NULL
that	NULL
alter	NULL
cysteine	NULL
216	NULL
function	NULL
(	NULL
43	NULL
,	NULL
67	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Abate	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1	NULL
)	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
redox	NULL
status	NULL
of	NULL
a	NULL
single	NULL
regulatory	NULL
cysteine	NULL
residue	NULL
present	NULL
in	NULL
the	NULL
dimerization	NULL
domains	NULL
of	NULL
c-Fos	NULL
and	NULL
c-Jun	NULL
tightly	NULL
control	NULL
the	NULL
assembly	NULL
of	NULL
these	NULL
proto-oncogene	NULL
products	NULL
to	NULL
form	NULL
the	NULL
inducible	NULL
AP-1	NULL
transcription	NULL
factor	NULL
complex	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Al	NULL
Baldwin	NULL
for	NULL
providing	NULL
the	NULL
IxBa	NULL
cDNA	NULL
,	NULL
Craig	NULL
Rosen	NULL
for	NULL
the	NULL
full-length	NULL
p65	NULL
cDNA	NULL
and	NULL
anti-ReIB	NULL
antiserum	NULL
,	NULL
A.	NULL
Israél	NULL
for	NULL
the	NULL
human	NULL
p105	NULL
cDNA	NULL
,	NULL
Mark	NULL
Hnatowich	NULL
for	NULL
critical	NULL
comments	NULL
,	NULL
and	NULL
Emily	NULL
Poyner	NULL
for	NULL
manuscript	NULL
preparation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Abate	NULL
,	NULL
C.	NULL
,	NULL
L.	NULL
Patel	NULL
,	NULL
F.	NULL
J.	NULL
Rauscher	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1990	NULL
.	NULL

Redox	NULL
regulation	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
DNA-binding	NULL
activity	NULL
in	NULL
vitro	NULL
.	NULL

Science	NULL
249:1157-1161	NULL
.	NULL

2	NULL
.	NULL

Andersson	NULL
,	NULL
S.	NULL
,	NULL
D.	NULL
Davis	NULL
,	NULL
H.	NULL
Dahiback	NULL
,	NULL
H.	NULL
Jornvall	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Russell	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
,	NULL
structure	NULL
,	NULL
and	NULL
expression	NULL
of	NULL
the	NULL
mito-chondrial	NULL
cytochrome	NULL
P-450	NULL
sterol	NULL
26-hydroxylase	NULL
,	NULL
a	NULL
bile	NULL
acid	NULL
biosynthetic	NULL
enzyme	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:8222-8229	NULL
.	NULL

3	NULL
.	NULL

Arima	NULL
,	NULL
N.	NULL
,	NULL
W.	NULL
A.	NULL
Kuziel	NULL
,	NULL
T.	NULL
A.	NULL
Grdina	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

IL-2-induced	NULL
signal	NULL
transduction	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:83-91	NULL
.	NULL

4	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

IxB	NULL
:	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
242:541-546	NULL
.	NULL

5	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
in	NULL
an	NULL
apparently	NULL
cytoplasmic	NULL
precursor	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
.	NULL

Cell	NULL
53:211-217	NULL
.	NULL

6	NULL
.	NULL

Baeuerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
65-kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-KB	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1689-1698	NULL
.	NULL

7	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
J.	NULL
Hoffman	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
gene	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
DNA-protein	NULL
interactions	NULL
flanking	NULL
the	NULL
xB	NULL
enhancer	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

1:83-92	NULL
.	NULL

8	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
P.	NULL
Peffer	NULL
,	NULL
H.	NULL
Bogerd	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
human	NULL
NF-	NULL
«	NULL
B	NULL
functions	NULL
as	NULL
a	NULL
potent	NULL
transcriptional	NULL
activator	NULL
and	NULL
a	NULL
target	NULL
for	NULL
v-rel-mediated	NULL
repression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1875-1879	NULL
.	NULL

9	NULL
.	NULL

Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
P.	NULL
Sista	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Molitor	NULL
,	NULL
E.	NULL
P.	NULL
Dixon	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
M.	NULL
Hannink	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
v-rel	NULL
oncogene	NULL
encodes	NULL
a	NULL
xB	NULL
enhancer	NULL
binding	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
function	NULL
.	NULL

Cell	NULL
63:803-814	NULL
.	NULL

10	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
S.	NULL
Finco	NULL
,	NULL
P.	NULL
V.	NULL
Nantermet	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1993	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxB	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3301-3310	NULL
.	NULL

11	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
R.	NULL
I.	NULL
Scheinman	NULL
,	NULL
S.	NULL
Haskill	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

IB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1899-1913	NULL
.	NULL

12	NULL
.	NULL

Bohnlein	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
W.	NULL
Lowenthal	NULL
,	NULL
M.	NULL
Sieckevitz	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
7834	NULL
13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

GANCHI	NULL
ET	NULL
AL	NULL
.	NULL

B.	NULL
R.	NULL
Franza	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
same	NULL
inducible	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
regulates	NULL
mitogen	NULL
activation	NULL
of	NULL
both	NULL
the	NULL
interleukin-2	NULL
receptor-alpha	NULL
gene	NULL
and	NULL
type	NULL
1	NULL
HIV	NULL
.	NULL

Cell	NULL
53:827-836	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
a	NULL
mitogen-inducible	NULL
gene	NULL
encoding	NULL
a	NULL
«	NULL
B-binding	NULL
protein	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
Rel	NULL
oncogene	NULL
and	NULL
to	NULL
cell-cycle	NULL
motifs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
348:76-80	NULL
.	NULL

Bours	NULL
,	NULL
V.	NULL
,	NULL
J.	NULL
Villalobos	NULL
,	NULL
P.	NULL
R.	NULL
Burd	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
novel	NULL
mitogen-inducible	NULL
gene	NULL
product	NULL
related	NULL
to	NULL
p50-p1l05-NF-KB	NULL
participates	NULL
in	NULL
transactivation	NULL
through	NULL
a	NULL
kB	NULL
site	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:685-695	NULL
.	NULL

Bradford	NULL
,	NULL
M.	NULL
M.	NULL
1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-254	NULL
.	NULL

Bressler	NULL
,	NULL
P.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
W.	NULL
Timmer	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
by	NULL
frans-dominant	NULL
p50	NULL
mutants	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:288-293	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
T.	NULL
Kanno	NULL
,	NULL
G.	NULL
Franzoso	NULL
,	NULL
and	NULL
U.	NULL
Siecbenlist	NULL
.	NULL

1993	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IkB-a	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2532-2536	NULL
.	NULL

Brownwell	NULL
,	NULL
E.	NULL
,	NULL
N.	NULL
Mittereder	NULL
,	NULL
and	NULL
N.	NULL
Rice	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
human	NULL
rel	NULL
proto-oncogene	NULL
cDNA	NULL
containing	NULL
an	NULL
Alu	NULL
fragment	NULL
as	NULL
a	NULL
potential	NULL
coding	NULL
exon	NULL
.	NULL

Oncogene	NULL
4:935-942	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
1989	NULL
.	NULL

Contingent	NULL
genetic	NULL
regulatory	NULL
events	NULL
in	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Science	NULL
243:355-361	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
S.	NULL
Park	NULL
,	NULL
M.	NULL
Tomita-Yamaguchi	NULL
,	NULL
K.	NULL
Kelly	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
candidate	NULL
oncoprotein	NULL
Bcl-3	NULL
is	NULL
an	NULL
antagonist	NULL
of	NULL
pSQ/NF-	NULL
«	NULL
B	NULL
mediated	NULL
inhibition	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
359:339-342	NULL
.	NULL

Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
S.-C.	NULL
Sun	NULL
,	NULL
W.	NULL
C.	NULL
Greene	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1992	NULL
.	NULL

IxB/MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transactivation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
3:1339-1352	NULL
.	NULL

Ghosh	NULL
,	NULL
P.	NULL
,	NULL
T.-H.	NULL
Tan	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
A.	NULL
Sica	NULL
,	NULL
and	NULL
H.	NULL
A	NULL
.	NULL

Young	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
interleukin	NULL
2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
:	NULL
c-Rel	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p65	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:1696-1700	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344	NULL
:	NULL
678-682	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
M.	NULL
Gifford	NULL
,	NULL
L.	NULL
R.	NULL
Riviere	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1990	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
p50	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
homology	NULL
to	NULL
re	NULL
?	NULL

and	NULL
dorsal	NULL
.	NULL

Cell	NULL
62:1019-1029.	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
1990	NULL
.	NULL

NF-kB	NULL
,	NULL
KBF1	NULL
,	NULL
dorsal	NULL
,	NULL
and	NULL
related	NULL
matters	NULL
.	NULL

Cell	NULL
62:841-843	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Ballard	NULL
.	NULL

1989	NULL
.	NULL

HIV-1	NULL
,	NULL
HTLV-1	NULL
and	NULL
normal	NULL
T-cell	NULL
growth	NULL
:	NULL
transcriptional	NULL
strategies	NULL
and	NULL
surprises	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
10:272-278	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
Beg	NULL
,	NULL
S.	NULL
M.	NULL
Tompkins	NULL
,	NULL
J.	NULL
S.	NULL
Morris	NULL
,	NULL
A.	NULL
P.	NULL
Yurochko	NULL
,	NULL
A.	NULL
Sampson-Johannes	NULL
,	NULL
K.	NULL
Mondal	NULL
,	NULL
P.	NULL
Ralph	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Baldwin	NULL
,	NULL
Jr.	NULL
1991	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
IxB-like	NULL
activity	NULL
.	NULL

Cell	NULL
65:1281-1289	NULL
.	NULL

Hatada	NULL
,	NULL
E.	NULL
N.	NULL
,	NULL
A.	NULL
Nieters	NULL
,	NULL
F.	NULL
G.	NULL
Wulczyn	NULL
,	NULL
M.	NULL
Naumann	NULL
,	NULL
R.	NULL
Meyer	NULL
,	NULL
G.	NULL
Nucifora	NULL
,	NULL
T.	NULL
W.	NULL
McKeithan	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
ankyrin	NULL
repeat	NULL
domains	NULL
of	NULL
the	NULL
NF-kappaB	NULL
precursor	NULL
p105	NULL
and	NULL
the	NULL
protooncogene	NULL
bel-3	NULL
act	NULL
as	NULL
specific	NULL
inhibitors	NULL
of	NULL
NF-kappaB	NULL
DNA	NULL
binding	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:2489-2493	NULL
.	NULL

Hazan	NULL
,	NULL
U.	NULL
,	NULL
D.	NULL
Thomas	NULL
,	NULL
J.	NULL
Alcami	NULL
,	NULL
F.	NULL
Bachelerie	NULL
,	NULL
N.	NULL
Israel	NULL
,	NULL
H.	NULL
Yssel	NULL
,	NULL
J.-L.	NULL
Virelizier	NULL
,	NULL
and	NULL
F.	NULL
Arenzana-Seisdedos	NULL
.	NULL

1990	NULL
.	NULL

Stimulation	NULL
of	NULL
a	NULL
human	NULL
T-cell	NULL
clone	NULL
with	NULL
anti-CD3	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
but	NULL
not	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
enhancer-dependent	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:7861-7865	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Gulino	NULL
,	NULL
and	NULL
F.	NULL
Ruscetti	NULL
.	NULL

1987	NULL
.	NULL

Cis-acting	NULL
transcriptional	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
gibbon	NULL
ape	NULL
leukemia	NULL
virus	NULL
(	NULL
GALV	NULL
)	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Virology	NULL
157:211-219	NULL
.	NULL

Hoyos	NULL
,	NULL
B.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
M.	NULL
Sieckevitz	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

<	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
:	NULL
role	NULL
in	NULL
the	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BroL	NULL
.	NULL

regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
244:457-460	NULL
.	NULL

Israél	NULL
,	NULL
A.	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
D.	NULL
Hatat	NULL
,	NULL
J.	NULL
Piette	NULL
,	NULL
M.	NULL
Kieran	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
D.	NULL
Wallach	NULL
,	NULL
M.	NULL
Fellous	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
.	NULL

1989	NULL
.	NULL

TNF	NULL
stimulates	NULL
expression	NULL
of	NULL
mouse	NULL
MHC	NULL
class	NULL
I	NULL
genes	NULL
by	NULL
inducing	NULL
an	NULL
NF-	NULL
«	NULL
B-like	NULL
enhancer	NULL
binding	NULL
activity	NULL
which	NULL
displaces	NULL
constitutive	NULL
fac-tors	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:3793-3800	NULL
.	NULL

Jamieson	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1991	NULL
.	NULL

Physiologic	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:416-420	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
A.-C.	NULL
Tran	NULL
,	NULL
M.	NULL
Grilli	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
subunit	NULL
regulation	NULL
in	NULL
nontransformed	NULL
CD4+	NULL
T	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256:1452-1456	NULL
.	NULL

Kemp	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Pearson	NULL
.	NULL

1990	NULL
.	NULL

Protein	NULL
kinase	NULL
recognition	NULL
sequence	NULL
motifs	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

15:342-346	NULL
.	NULL

Kieran	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Blank	NULL
,	NULL
F.	NULL
Logeat	NULL
,	NULL
J.	NULL
Vandekerckhove	NULL
,	NULL
F.	NULL
Lott-speich	NULL
,	NULL
O	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
M.	NULL
B	NULL
.	NULL

Urban	NULL
,	NULL
P.	NULL
Kourilsky	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
A.	NULL
Israel	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
subunit	NULL
of	NULL
NF-kB	NULL
is	NULL
identical	NULL
to	NULL
factor	NULL
KBF1	NULL
and	NULL
homologous	NULL
to	NULL
the	NULL
ref	NULL
oncogene	NULL
product	NULL
.	NULL

Cell	NULL
62:1007-1018	NULL
.	NULL

Kumar	NULL
,	NULL
S.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rabson	NULL
,	NULL
and	NULL
C.	NULL
Gélinas	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
RxxRxRxxC	NULL
motif	NULL
conserved	NULL
in	NULL
all	NULL
Rel/kB	NULL
proteins	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
DNA-binding	NULL
activity	NULL
and	NULL
redox	NULL
regulation	NULL
of	NULL
the	NULL
v-Rel	NULL
oncoprotein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3094-3106	NULL
.	NULL

Kunsch	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
M.	NULL
Ruben	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

Selection	NULL
of	NULL
optimal	NULL
«	NULL
B/Rel	NULL
DNA-binding	NULL
motifs	NULL
:	NULL
interaction	NULL
of	NULL
both	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
DNA	NULL
is	NULL
required	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:4412-4421	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

NF-kB	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
58:227-229.	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
E.	NULL
Bohnlein	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
induces	NULL
proteins	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
«	NULL
B-like	NULL
enhancer	NULL
elements	NULL
and	NULL
regulate	NULL
interleukin-2	NULL
receptor	NULL
alpha	NULL
chain	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2331-2335	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DiDonato	NULL
,	NULL
C.	NULL
Rosette	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1993.	NULL
p105	NULL
and	NULL
p98	NULL
precursor	NULL
proteins	NULL
play	NULL
an	NULL
active	NULL
role	NULL
in	NULL
NF-KB-mediated	NULL
signal	NULL
transduction	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:705-718	NULL
.	NULL

Meyer	NULL
,	NULL
R.	NULL
,	NULL
E.	NULL
N.	NULL
Hatada	NULL
,	NULL
H.-P.	NULL
Hohmann	NULL
,	NULL
M.	NULL
Haiker	NULL
,	NULL
C.	NULL
Bartsch	NULL
,	NULL
U.	NULL
Rithlisberger	NULL
,	NULL
H.-W.	NULL
Lahm	NULL
,	NULL
E.	NULL
J.	NULL
Schlaeger	NULL
,	NULL
A.	NULL
P.	NULL
van	NULL
Loon	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
DNA-binding	NULL
subunit	NULL
of	NULL
human	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
:	NULL
the	NULL
level	NULL
of	NULL
its	NULL
mRNA	NULL
is	NULL
strongly	NULL
regulated	NULL
by	NULL
phorbol	NULL
ester	NULL
or	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:966-970	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1991	NULL
.	NULL

«	NULL
B-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
are	NULL
differentially	NULL
inhibited	NULL
by	NULL
enhancer	NULL
mutations	NULL
and	NULL
biological	NULL
oxidation	NULL
.	NULL

New	NULL
Biol	NULL
.	NULL

3:987-996.	NULL
.	NULL

Molitor	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
H.	NULL
Walker	NULL
,	NULL
S.	NULL
Doerre	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
family	NULL
of	NULL
inducible	NULL
and	NULL
differentially	NULL
expressed	NULL
enhancer-binding	NULL
proteins	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:10028-10032	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
P.	NULL
Hamer	NULL
,	NULL
A.	NULL
J.	NULL
Capobianco	NULL
,	NULL
R.	NULL
A.	NULL
Laurensen	NULL
,	NULL
and	NULL
T.	NULL
D.	NULL
Gilmore	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
protein	NULL
kinase-A	NULL
recognition	NULL
sequence	NULL
is	NULL
structurally	NULL
linked	NULL
to	NULL
transformation	NULL
by	NULL
p59¢	NULL
``	NULL
*	NULL
``	NULL
and	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
p68	NULL
``	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:5867-5877	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
326:711-713	NULL
.	NULL

Nakamaye	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
F.	NULL
Eckstein	NULL
.	NULL

1986	NULL
.	NULL

Inhibition	NULL
of	NULL
restriction	NULL
endonuclease	NULL
Nci	NULL
I	NULL
cleavage	NULL
by	NULL
phosphorothioate	NULL
groups	NULL
and	NULL
its	NULL
application	NULL
to	NULL
oligonucleotide-directed	NULL
mutagenesis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:9679-9698	NULL
.	NULL

Neri	NULL
,	NULL
A.	NULL
,	NULL
C.-C.	NULL
Chang	NULL
,	NULL
L.	NULL
Lombardi	NULL
,	NULL
M.	NULL
Salina	NULL
,	NULL
P.	NULL
Corradini	NULL
,	NULL
A.	NULL
T.	NULL
Maiolo	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
Chananti	NULL
,	NULL
and	NULL
R.	NULL
Dalla-Favera	NULL
.	NULL

1991	NULL
.	NULL

B	NULL
cell	NULL
Iymphoma-associated	NULL
chromosomal	NULL
translocation	NULL
involves	NULL
candidate	NULL
oncogene	NULL
lyt-10	NULL
,	NULL
homologous	NULL
to	NULL
NF-kB	NULL
p50	NULL
.	NULL

Cell	NULL
67:1075-1087	NULL
.	NULL

Neumann	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
C.	NULL
Morency	NULL
,	NULL
and	NULL
K.	NULL
Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

Biotechniques	NULL
5:444-447	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
H.-C.	NULL
Liou	NULL
,	NULL
P.	NULL
Tempst	NULL
,	NULL
and	NULL
D.	NULL
Balti-	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

61.	NULL
more	NULL
.	NULL

1991	NULL
.	NULL

DNA	NULL
binding	NULL
and	NULL
IB	NULL
inhibition	NULL
of	NULL
the	NULL
cloned	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
a	NULL
re/-related	NULL
polypeptide	NULL
.	NULL

Cell	NULL
64:961-969	NULL
.	NULL

Ohno	NULL
,	NULL
H.	NULL
,	NULL
G.	NULL
Takimoto	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
McKeithan	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
candidate	NULL
proto-oncogene	NULL
bel-3	NULL
is	NULL
related	NULL
to	NULL
genes	NULL
implicated	NULL
in	NULL
cell	NULL
lineage	NULL
determination	NULL
and	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Cell	NULL
60:991-997	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2336-2340	NULL
.	NULL

Perkins	NULL
,	NULL
N.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Schmid	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
N.	NULL
R.	NULL
Rice	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1992	NULL
.	NULL

Distinct	NULL
combinations	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
determine	NULL
the	NULL
specificity	NULL
of	NULL
transcriptional	NULL
activation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:1529-1533	NULL
.	NULL

Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
M.	NULL
L.	NULL
Mackichan	NULL
,	NULL
and	NULL
A.	NULL
Israél	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
precursor	NULL
of	NULL
NF-xB	NULL
has	NULL
IxB-like	NULL
functions	NULL
.	NULL

Cell	NULL
71:243-253	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
P.	NULL
J.	NULL
Dillon	NULL
,	NULL
R.	NULL
Schreck	NULL
,	NULL
T.	NULL
Henkel	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1991	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
rel-related	NULL
human	NULL
cDNA	NULL
that	NULL
potentially	NULL
encodes	NULL
the	NULL
65-kD	NULL
subunit	NULL
of	NULL
NF-kB	NULL
.	NULL

Science	NULL
251:1490-1493	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
J.	NULL
F.	NULL
Klement	NULL
,	NULL
T.	NULL
A.	NULL
Coleman	NULL
,	NULL
M.	NULL
Maher	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

I-Rel	NULL
:	NULL
a	NULL
novel	NULL
rel-related	NULL
protein	NULL
that	NULL
inhibits	NULL
NF-	NULL
«	NULL
B	NULL
transcriptional	NULL
activity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:745-760	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
R.	NULL
Narayanan	NULL
,	NULL
J.	NULL
F.	NULL
Kiement	NULL
,	NULL
C.-H.	NULL
Chen	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1992	NULL
.	NULL

Functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transcriptional	NULL
activator	NULL
and	NULL
an	NULL
alternatively	NULL
spliced	NULL
deriv-ative	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:444-454	NULL
.	NULL

Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
P.	NULL
Bull	NULL
,	NULL
M.	NULL
Takamiya	NULL
,	NULL
V.	NULL
Bours	NULL
,	NULL
U.	NULL
Siebenlist	NULL
,	NULL
P.	NULL
Dobrzanski	NULL
,	NULL
and	NULL
R.	NULL
R.	NULL
Bravo	NULL
.	NULL

1992	NULL
.	NULL

RelB	NULL
,	NULL
a	NULL
new	NULL
rel	NULL
family	NULL
transcription	NULL
activator	NULL
that	NULL
can	NULL
interact	NULL
with	NULL
p50-NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:674-684	NULL
.	NULL

Schmid	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
N.	NULL
D.	NULL
Perkins	NULL
,	NULL
C.	NULL
S.	NULL
Duckett	NULL
,	NULL
P.	NULL
C.	NULL
Andrews	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1991	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
NF-kB	NULL
subunit	NULL
which	NULL
stimulates	NULL
HIV	NULL
transcription	NULL
in	NULL
synergy	NULL
with	NULL
p65	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
352:733-736.	NULL
.	NULL

Schmitz	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeverle	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:3805-3817	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Muller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

HOMODIMERIZATION	NULL
OF	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
7835	NULL
1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baitimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
k	NULL
immunoglob-ulin	NULL
enhancer-binding	NULL
protein	NULL
NF-kB	NULL
by	NULL
a	NULL
posttranslational	NULL
mechanism	NULL
.	NULL

Cell	NULL
47:921-928	NULL
.	NULL

Shirakawa	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
Mizel	NULL
.	NULL

1989	NULL
.	NULL

In	NULL
vitro	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
catalyzed	NULL
by	NULL
cyclic	NULL
AMP-dependent	NULL
protein	NULL
kinase	NULL
and	NULL
protein	NULL
kinase	NULL
C.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2424-2430.	NULL
.	NULL

Stein	NULL
,	NULL
B.	NULL
,	NULL
H.	NULL
Rahmsdorf	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
M.	NULL
Litfin	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1989	NULL
.	NULL

UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
metallothionein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:5169-5181	NULL
.	NULL

Sun	NULL
,	NULL
S.-C.	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1993	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912-1915	NULL
.	NULL

Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
D.	NULL
Ghosh	NULL
,	NULL
F.	NULL
Trinh	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

N-terminal	NULL
DNA-binding	NULL
domains	NULL
contribute	NULL
to	NULL
differential	NULL
DNA-binding	NULL
specificities	NULL
of	NULL
NF-kB	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:852-860	NULL
.	NULL

Toledano	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1991	NULL
.	NULL

Modulation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
binding	NULL
activity	NULL
by	NULL
oxidation-reduc-tion	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:4328-4332	NULL
.	NULL

Urban	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
P.	NULL
A.	NULL
Baeuerie	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
65-kDa	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
is	NULL
a	NULL
receptor	NULL
for	NULL
IxB	NULL
and	NULL
a	NULL
modulator	NULL
of	NULL
DNA-binding	NULL
specificity	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1975-1984	NULL
.	NULL

Walker	NULL
,	NULL
W.	NULL
H.	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
P.	NULL
A.	NULL
Ganchi	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Hoffman	NULL
,	NULL
P.	NULL
A.	NULL
Kaufman	NULL
,	NULL
D.	NULL
W.	NULL
Ballard	NULL
,	NULL
M.	NULL
Hannink	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
v-rel	NULL
oncogene	NULL
:	NULL
insights	NULL
into	NULL
the	NULL
mechanism	NULL
of	NULL
transcriptional	NULL
activation	NULL
,	NULL
repression	NULL
,	NULL
and	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66	NULL
:	NULL
5018-5029	NULL
.	NULL

Wulezyn	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
M.	NULL
Naumann	NULL
,	NULL
and	NULL
C.	NULL
Scheidereit	NULL
.	NULL

1992	NULL
.	NULL

Candidate	NULL
proto-oncogene	NULL
bel-3	NULL
encodes	NULL
a	NULL
subunit-specific	NULL
inhibitor	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
358:597-599	NULL
.	NULL

Yano	NULL
,	NULL
O.	NULL
,	NULL
J.	NULL
Kanellopoulos	NULL
,	NULL
M.	NULL
Kieran	NULL
,	NULL
O.	NULL
Le-Bail	NULL
,	NULL
A.	NULL
Israél	NULL
,	NULL
and	NULL
P.	NULL
Kourilsky	NULL
,	NULL
1987	NULL
.	NULL

Purification	NULL
of	NULL
KBF1	NULL
,	NULL
a	NULL
common	NULL
factor	NULL
binding	NULL
to	NULL
both	NULL
H-2	NULL
and	NULL
beta	NULL
2-microglobulin	NULL
enhancers	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:3317-3324	NULL
.	NULL

